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In the Eukaryotes, DNA sequences in genes are often interrupted by non-coding sequences called
introns. These sequences are removed from the transcripts via a process known as splicing either 
while the genes are being transcribed (co-transcriptionally) or after transcription (post-
transcriptionally). In higher eukaryotes two separate pre-mRNA splicing machineries have been 
described: the U12-dependent spliceosome which is responsible for splicing of approximately 
700-800 unique introns (known as the U12-type introns), and the U2-dependent spliceosome 
responsible for splicing all other introns (known as the U2-type introns). The two intron types 
show divergent sequence elements in their 5' splice site and branch point sequences. In addition, 
earlier reports have indicated that U12-type introns are spliced with a slower rate comparing to 
the U2-type introns, suggesting that the splicing of U12-type introns is rate-limiting to the 
expression of the U12-type intron containing genes. This slower splicing is manifested as 
unspliced or retained U12-type introns in the otherwise fully processed mRNA products. 
In this work I developed a novel computational tool called the intron-exon retention estimator 
(IntEREst) which allows accurate detection, quantification and differential analysis of the intron 
retention levels from RNAseq data. Additional features of IntEREst include a tool for 
identification of U12-type introns, and a number of tools to compare the retention levels of user-
defined subclasses of introns across several samples. An already published RNAseq dataset 
(available under accession  GSE63816 in NCBI Gene expression Omnibus database) from 
patients and control subjects of myelodysplastic syndrome (MDS) was used to assess the 
functionality by benchmarking IntEREst. This dataset included RNAseq data from MDS patients
featuring mutations in the ZRSRS2 gene that functions in the recognition of U12-type introns, 
and from control subjects that were either healthy or MDS patients without ZRSR2 mutations. 
Additionally, I used a Maize dataset consisting of samples with mutated and wild-type RGH3 
gene, which is an ortholog of human ZRSR2. My results indicate that IntEREst is a reliable tool 
for analyzing intron retention events from RNAseq data producing comparable or better results 
than the other similar methods. 
I used IntEREst to globally compare the retention of the U12-type introns to that of U2-type 
introns. I found that U12-type introns show on average a 2-fold higher retention levels compared
to that of U2-type introns both in human and plant cells. This result recapitulates the findings 
from earlier studies using a small set of selected genes and generalizes the increased intron 
retention of U12-type introns to a genome-wide scale. Furthermore, the results of this work 
provide evidence that transcripts containing unspliced U12-type introns are degraded in the 
nucleus by the nuclear exosome. Together, these results support the hypothesis that U12-type 
introns are globally spliced less efficiently than the U2-type introns and can thus regulate the rate
of mature mRNA formation with the genes containing U12-type introns. Additionally, intron 
retention analysis of human/plant cells containing mutations in the U12-dependent spliceosome 
showed that such defects lead to a further increase in the levels of unspliced U12-type introns. 
In conclusion, this thesis extends current knowledge concerning the significance of the correct 
splicing of U12-type introns and the consequences of their abnormal splicing. Furthermore, it 
describes a combination of available tools together with a novel software tool (i.e. IntEREst) that
can be used to measure and compare the efficiency and accuracy of RNA splicing across 
multiple samples. We show that these tools can reveal valuable information about the molecular 




1.1. Spliceosomal introns and pre-mRNA splicing
Most nuclear genes in higher eukaryotes feature non-coding sequences called introns, which are 
absent from the final mRNAs and therefore are not coded to proteins (Gilbert, 1978; Berget et 
al., 1977; Chow et al., 1977; Evans et al., 1977). These sequences are removed by a 
ribonucleoprotein complex called the spliceosome, hence they bear the name “spliceosomal 
introns”.  They are completely absent from prokaryotes and are present in varied numbers (from 
hundreds to hundreds of thousands) across eukaryotes. For example in humans more than 
200,000 spliceosomal introns have been reported (Sakharkar et al., 2004). The presence of these 
introns in many eukaryotes, together with the conservation of their positions across various 
lineages of eukaryotes suggests the existence of introns and a nascent spliceosome in the last 
common ancestor (i.e. cenancestor) of eukaryotes (Roy and Gilbert, 2006, 2005; Rogozin et al., 
2003). It is thought that the cenancestor of eukaryotes probably featured a significant number of 
introns and although some modern eukaryotes show evidence of intron gain, e.g. 81 gained 
introns in C. elegans and 41 in C. briggsae (Coghlan and Wolfe, 2004), throughout evolution 
introns had a tendency to be lost rather than new ones being inserted (Roy and Gilbert, 2005, 
2006). This is not unexpected since introns carry several burdens to the genome: cell needs to 
make extensive investments to both replicate and transcribe the intronic sequences that will be 
excised and degraded nearly immediately after their synthesis (Beyer et al., 1981; Beyer and 
Osheim, 1988). Mutations on the intron splice sites or any defective spliceosome causing 
mutation may lead to failure to detect and/or remove introns from transcripts (discussed in detail 
in section 1.2). Moreover, excised introns in the nucleus must be degraded. 
However, several benefits have also been ascribed for introns: emergence of new genes as a 
result of recombination within introns and ‘exon-shuffling’ (Gilbert, 1978; reviewed by Patthy, 
1999); improved fitness by promoting intragenic recombination (Gilbert, 1978; Comeron and 
Kreitman, 2000); regulation of transcription by housing transcription enhancers and suppressors 
(Rossi and de Crombrugghe, 1987; Stergachis et al., 2013); increased flexibility for genes to 
code multiple products as a result of alternative splicing (described in detail in section 1.2); 
enhanced gene expression (Gruss et al., 1979; Callis et al., 1987); control of chromatin assembly
and mRNA transport (Luo and Reed, 1999; Valencia et al., 2008; Schwartz et al., 2009; Spies et 
al., 2009);  enhance mRNA quality control through nonsense-mediated mRNA decay (i.e. 
NMD);  NMD regulation through exon junction complexes (Le Hir et al., 2001); and lastly, 
generation of stable RNA products, e.g. small nucleolar RNAs (snoRNA) and microRNAs 
(miRNA)(Smith and Steitz, 1998; Dieci et al., 2009; Ambros et al., 2003). In a few cases the 
intron-coded RNAs are the stable products emerging from the primary transcript while the fully 
spliced mRNA is degraded (Tycowski et al., 1996; Moore, 1996). Notably although these 
benefits were probably effective in driving the introns to long-term fixation, they were influential
only after the introns were already established. However, there have been attempts to explain the 
origin of introns (with their many burdens on the genome) using other non-adaptive reasons as 
the basis for such arguments. One such theory claims that mildly deleterious insertions such as 
those that led to the origin of introns may be tolerated if the effective population is sufficiently 
small; i.e. conditions that probably the cenancestor of eukaryotes lived under (Lynch, 2002). 
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1.1.1. Did introns emerge late or early during evolution?
The widespread presence of introns in various eukaryote lineages and their scarcity in 
prokaryotes has led to heated debates and disagreements over the time of their origins. 
Specifically, there are two main theories of the origins of introns: the "introns early" theory 
postulates that the early ancestral genomes were mainly built up of short exons separated by 
introns which, through exon-shuffling, facilitated the construction of complex gene structures of 
the present day. This theory further postulates that the introns were present in the genome of the 
common ancestor of eukaryotes and prokaryotes but they were lost during the evolution of 
prokaryotes, possibly due to selection favoring maximal growth and streamlined genomes, 
resulting in modern intron-less prokaryotes  (Darnell, 1978; Doolittle, 1978; Gilbert, 1987). In 
contrast, the "introns late" theory argues that the genome of the ancestors of eukaryotes and 
prokaryotes lacked introns and resembled those of modern prokaryotes. Consequently, according
to this theory the introns were later inserted into the already existing intron-less genes (Cavalier-
Smith, 1991; Palmer and Logsdon, 1991). 
Although completely devoid of spliceosomal introns, it is known that prokaryotes include other 
non-spliceosomal types of introns, i.e. group I, group II self-splicing introns and tRNA introns 
(Belfort et al., 1995). The tRNA introns are found in tRNA genes of eukaryotes and archaea. 
They are usually located at their canonical position (i.e. upstream the anticodon) and their 
removal from the RNA is dependent on protein components. In contrast, group I and II are self-
splicing introns. They are present in mRNA, tRNA and rRNA of bacteria, chloroplasts, 
mitochondria, viruses and lower eukaryotes, but are absent from nuclear genomes of the 
multicellular eukaryotes. However, the group II introns have been described in the chloroplasts 
and mitochondria of several multicellular eukaryotes (e.g. plants and fungi). Extensive evidence 
suggests that the present group II self-splicing introns and spliceosomal introns share a common 
evolutionary ancestry. Specifically, in addition to a similar catalytic mechanism between group II
self-splicing introns and spliceosomal intron excision, sequence and structural data support the 
hypothesis that snRNA components of the nuclear spliceosomes have a strong resemblance to 
individual RNA domains in the group II self-splicing introns. Conversely, the excision of 
spliceosomal introns is known to be catalyzed by snRNA components of the spliceosome 
(Valadkhan and Manley, 2001; Shukla and Padgett, 2002; Yan et al., 2015; Papasaikas and 
Valcarcel, 2016). Thus it is likely that spliceosomal snRNAs and presumably also at least some 
spliceosomal introns have originated from group II introns that either were transferred from other
sources  (e.g. the primordial mitochondrion or a bacterium), or had prior residence in the nucleus
of eukaryotes  (Cavalier-Smith, 1991; Lynch, 2007; Zimmerly and Semper, 2015). Recent 
developments, e.g. the discovery of presence of self-splicing introns in genomes of some 
prokaryotes and the ancestral relationship of group II introns to the spliceosomal snRNAs, render
the introns late theory (at least in its extreme form mentioned above) to be highly unlikely. Note 
that hereafter for the sake of simplicity, I will use the term ‘intron’ without clarifying the specific
group, to refer to ‘spliceosomal introns’. 
1.1.2. U2- and U12-type introns
There are two known types of spliceosomal introns, namely U2- and U12-type introns. 
Mammalian genomes contain ~ 700-800 U12-type as compared with the ~ 200 000 U2-type 
introns. Hence the U12-type introns are also known as the ‘minor’ introns and the U2-type 
introns as the “major” introns (Turunen et al., 2013). U12-type introns are present in the nuclear 
genomes of diverse eukaryotic lineages. They are present in the genome of vertebrates (at least 
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mammals, birds, fish, and amphibians), several insect species (e.g. Drosophila melanogaster and
silkworm i.e. Bombyx mori), in Cnidarians (e.g. jellyfish), various plants (e.g. Arabidopsis 
thaliana and maize i.e. Zea mays) and even in a number of protists (Russell et al., 2006); and 
they are absent from several species such as the yeast Saccharomyces cerevisiae, nematode 
Caenorhabditis elegans, and most eukaryotic microbes (e.g. algae, protists and fungai)  (Burge 
et al., 1998; Alioto, 2007). The two classes of introns feature distinct consensus sequences on 
their 5′ and 3′ splice sites (ss) and the branch point sequence. Two subclasses of U12-type introns
have been described: GT-AG subtype with GT and AG dinucletides at their intron 5′ and 3′ 
termini, and a less frequent AT-AC subtype with AT and AC dinucleotides at the respective 
termini (Dietrich et al., 1997; Wu and Krainer, 1997; Burge et al., 1998). Usually genes are 
either completely devoid of U12-type introns or include only a single U12-type intron together 
with one or several U2-type introns. Exceptions do, however, exist; e.g. the human genes 
SPTSSA and CCDC56 each feature solely a U12-type intron, and several genes feature more than
one U12-type intron, e.g. DERL2 has two U12-type and four U2-type introns. The genes that 
contain U12-type introns are mainly associated with ‘information processing’; on the other hand 
genes related to basic energy metabolism, fatty acid and phospholipid biosynthesis pathways 
lack these introns (Burge et al., 1998).
Besides the rarity of U12-type introns compared to the U2-type, several other differences 
between the two intron types have also been noted: first, U12-type introns feature a more 
conserved 5′ss and branch point site compared to the U2-type introns (figure 1) (Levine and 
Durbin, 2001; Lopez and Seraphin, 1999). Furthermore, the distances of the branch points to the 
3′ss are more restricted in the U12-type introns, i.e. generally in the range of [-21,-8] nucleotides 
upstream of the 3′ss. Additionally, U12-type introns show no or very weak polypyrimidine tract 
downstream of their branch site and upstream of their 3′ss compared to in the U2-type introns. 
These conserved features are essential for proper U12-type intron recognition and in fact, 
mutations in the 5′ss of the U12-type introns can convert them to U2-type introns/5′ss (Dietrich 
et al., 1997; Burge et al., 1998), Also, U12-type branch point sequences located at positions 
beyond the [-20,-10] window relatively to 3′ss have been shown to lead to activation of cryptic 
U2-type splice sites (Dietrich et al., 2001). The highly conserved sequences at the U12-type 5′ss 
and branch sites/3′ss suggest that they are more inclined to be correctly recognized even in the 
absence of external splicing factors which typically assist splice site recognition with the U2-
type introns (1.2) (Abril et al., 2005; Sheth et al., 2006). The average size of the two introns are 
not drastically different, i.e. ~3600 bp for the U12-type introns vs ~4130 for the U2-type. 
However, in contrast to U2-type introns (where their size peaks around 90 bp) U12 type introns 
with sizes smaller than 100 bp are extremely rare (Levine and Durbin, 2001).
 
Figure 1. Consensus sequences of 5′ ss, 3′ ss and branch points of U12 and U2 type introns. Adapted
from (Turunen, Niemelä, et al., 2013)
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1.1.3. U2- vs U12-type spliceosome
As mentioned previously introns are recognized and removed by a ribonucleoprotein complex 
called the spliceosome. The U2-dependent spliceosome (also known as major spliceosome) 
consists of 5 small nuclear RNAs (snRNAs), which, together with protein factors make up small 
nuclear ribonucleoproteins (snRNPs), i.e. U1, U2, U4, U5, and U6 (Will and Lührmann, 2011; 
Matera and Wang, 2014). As shown in figure 2, initially U1 snRNP recognizes the 5′ ss of the 
U2-type intron while a non-snRNP protein factor SF1 (described in 1.2) detects the branch point 
(Mount et al., 1983; Zhuang and Weiner, 1986; Liu et al., 2001). Subsequently, a U2AF 
heterodimer consisting of 65 kDa and 35 and kDa subunits bind to polypyrimidine tract and 3′ ss,
respectively, and form the E complex (Zamore and Green, 1989; Zorio and Blumenthal, 1999). 
The A complex is formed by U2 being recruited by U2AF1 to replace SF1 at the branch point 
(Ruskin et al., 1988; Valcarcel et al., 1996). Subsequently, the U2 snRNA forms base pairing 
with the branch site which causes the branch site adenosine to bulge out. The adenosine 2’ 
hydroxyl can function in the later catalytic steps (Wu and Manley, 1989; Query et al., 1994). 
Later, a tri-snRNP formed by U4, U5 and U6 associate to the spliceosome which leads to a 
dissociation of the U1 snRNP, thus forming the B complex  (Konarska and Sharp, 1987). After a 
large number of rearrangements in RNA-RNA interactions and in protein composition (Will and 
Lührmann, 2011), the spliceosome reaches catalytically active conformation (B*) and catalyzes 
the first step of splicing (Wu and Manley, 1989; Query et al., 1994). Splicing factors associate to 
assist spliceosome undergo further conformational changes that leads to forming C complex. 
Eventually the complex is disassembled and the lariat intron is released. The disassembled 
spliceosome components are recycled for use in later splicing reactions (Tsai et al., 2005). 
In comparison, the U12-dependent spliceosome (minor spliceosome) includes four specific 
snRNAs, namely U11, U12, U4atac and U6atac; however, it also shares the U5 snRNA with the 
U2-dependent spliceosome. The U12-dependent spliceosome includes seven specific protein 
components which all are located in the U11/U12 di-snRNP and not found in the U2-dependent 
spliceosome (table 1). The assembly of the U12-dependent spliceosome is overall similar to that 
of major spliceosome except for the differences in the initial intron recognition stage  (Patel and 
Steitz, 2003) (see figure 2). Initially, the U11 and U12 snRNPs (as a preformed U11/U12 di-
snRNP) bind simultaneously to the 5′ ss and the branch point sequence of the U12-type introns 
(Frilander and Steitz, 1999). As opposed to U1 snRNP, U11 neither form base-pairing 
interactions beyond the exon-intron boundary nor with the first 3 bases of the U12-type 5′ ss 
(Hall and Padgett, 1994; Kolossova and Padgett, 1997).  Instead these nucleotides are recognized
by the 48K protein (Turunen et al., 2008). As mentioned previously, U12-type introns do not 
have a defined polypyrimidine tract and hence the U2AF65/35 heterodimer does not function in 
the recognition of U12-type introns. Rather, this recognition is more dependent on RNA/RNA 
interactions at the branch point sequence (Brock et al., 2008). After U12 binding, the branch site 
adenosine is bulged out similarly as in the major spliceosome (Tarn and Steitz, 1996). Binding 
ZRSR2 (URP) protein (and possibly ZRSR1 (Horiuchi et al., 2018)) is needed for the 3′ ss 
recognition and A complex formation (Shen et al., 2010). Next, the U4atac/U6atac.U5 tri-snRNP
enters the nascent spliceosome and similarly as in the major spliceosome this leads to a 
dissociation of U11 snRNP from the 5′ ss and pairing formation of U6atac/5′ ss interaction. 
Subsequent RNA-RNA rearrangements lead to unwinding of U4atac/U6atac duplex, dissociation
of U4atac from the complex, and base pairings between U6atac and U12 (B complex). These 
lead to catalytic core formation (Tarn and Steitz, 1996; Frilander and Steitz, 2001) and 
juxtaposition of the 5′ ss and the branch point adenosine for the first catalytic step. Following the
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exon ligation the lariat intron is released. Similar to the U2-dependent spliceosome, the 
spliceosome components are disassembled and recycled (Damianov et al., 2004).
Figure 2. U2-dependent (on the left) and U12-dependent (on the right) spliceosome assembly, 
including labels that show the formation of E, A, B* and C complexes. Adapted from (Turunen, 
Niemelä, et al., 2013)
1.1.4. The origins of the major and minor spliceosomes and introns
Since their discovery, various theories have been proposed regarding the origin of the U12-
dependent spliceosome and its evolution in relation to that of U2-dependent spliceosome. A 
prevalent theory is the so-called fission/fusion model which postulates that both spliceosomes 
are descendants of the same ancient spliceosome which initially evolved independently 
(presumably in separate organismal lineages) thus leading to fission of the original spliceosome 
to two separate lineages. A subsequent fusion of these organism led to their coexistence in a 
single cell/genome (Burge et al., 1998). The three main points in support of the fission/fusion 
model are: i) the presence of U12-type introns in higher proportions in the U12 genes (i.e. U12-
type intron containing genes) compared to their expected proportions if they were randomly 
distributed, ii) the relatively over-representation of nonhomologous U12-type introns in 
paralogous genes, and iii) the association of the U12-type introns with information processing 
functions (Burge et al., 1998). The main criticism against this model is that for the fission-fusion 
to be possible it needs to fulfill two opposing conditions: the dissimilarities between the two 
lineages at the isolation stage would have had to be both high enough to allow the retention of 
their separate functions upon reuniting, and low enough to allow the two hybridized lineages to 
be reproductively compatible; i.e. conditions that were unlikely to coexist. Moreover, the number
9
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of introns in the host genomes (in isolation stage) would have had to be effectively small enough 
to allow all of them to be spliced (Lynch and Richardson, 2002; Lynch, 2007). Moreover, 
evidence exists that the spliceosomal machinery is evolutionary relatively stable; e.g. despite the 
billion years of separation yeasts can splice mammalian introns (Trachtulec and Forejt, 1999; 










Sm proteins: B/B', 
D1, D2, D3, E, F, 
and G
✓ ✓ ✓ snRNP core components (Will and Lührmann, 
2011)
U1‐A (SNRPA) ✓ Structural; RNA‐binding (Pomeranz Krummel et
al., 2009)
U1‐C (SNRPC) ✓ 5′ss recognition (Pomeranz Krummel et al., 2009)
U1‐70K 
(SNRNP70)
✓ Structural; SR protein interactions(Pomeranz 
Krummel et al., 2009; Cho et al., 2011)
U2A′ (SNRPA1) ✓ Structural; RNA-binding
U2B′′ (SNRPB2) ✓ Structural; RNA-binding
SF3a complex ✓ BPS binding (Gozani et al., 1996)
SF3b complex ✓ ✓ BPS binding (Gozani et al., 1996; Will and 
Lührmann, 2011)
20K (ZMAT5) ✓ Unknown; homology to U1C (Will et al., 2004)
25K (SNRNP25) ✓ Unknown (Will et al., 2004)
31K (ZCRB1) ✓ Unknown; RNA-binding (Kim et al., 2010)
35K (SNRNP35) ✓ SR protein interactions, homology to U1-70K 
(Will et al., 1999; Lorkovic et al., 2004, 2005)
48K (SNRNP48) ✓ 5′ ss recognition (Turunen et al., 2008)
59K (PDCD7) ✓ Structural, binds 48K and 65K (Benecke et al., 
2005; Turunen et al., 2008)
65K (RNPC3) ✓ Structural, binds U12 snRNA (Benecke et al., 
2005; Norppa et al., 2018)
ZRSR2 (URP) ✓ 3′ ss recognition (Shen et al., 2010)
ZRSR1 ✓ Intron-less active pseudo gene of ZRSR2 with 
similar function (Horiuchi et al., 2018)
hPrp43 (DHX15) ✓ ✓
Y Box-1 (YBX1) ✓
Table 1.  Comparison of the protein composition of the major spliceosome U1 and U2 snRNPs and 
the minor spliceosome U11/U12 di-snRNPs, which both function in the initial intron recognition. 
Adapted from (Turunen, Niemelä, et al., 2013). Note that the ZRSR2/Urp and Y Box-1 are present in
the Major spliceosome but absent from U1 or U2 snRNPs.
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An alternative theory proposes that origins of the two type of introns (and spliceosomes) are two 
organellar group II introns that invaded the primordial nuclear genome (Lynch and Richardson, 
2002). Accordingly, the similarities between the two splicing machinery are due to convergence, 
and the sparseness of the U12-type introns in comparison to the U2-type was later reached (or 
exacerbated) upon loss or conversion of the U12-type introns to the U2-type. As mentioned in 
section 1.1.2 the 5′ ss and branchpoint consensus sequences of the U12-type introns are more 
conserved compared to that of U2-type and mutations in their sequences have shown to convert 
the introns. In case of complete loss of U12-type introns, similar to in C. Elegans, the minor 
spliceosome would eventually be degenerated preventing any future recolonization of the U12-
type introns (Bartschat and Samuelsson, 2010). 
1.2. Alternative splicing
When the human genome was first sequenced in early 2000s, initial analysis suggested that the 
number of protein coding genes in human were about 20,000 to 25,000 (International Human 
Genome Consortium, 2004). This raised the question of how a limited number of genes can code 
for a great variety of known phenotypes and functions? In response, alternative splicing (AS) 
was suggested as a process by which genes can code for many phenotypes (International Human 
Genome Consortium, 2001). AS is referred to as various combinations of splicing of introns in 
pre-mRNAs that can lead to different combinations of exons being included in the mRNAs. It 
has recently been discovered that most mammalian genes (e.g. > 95% of human genes) can 
produce multiple mRNAs through this process (Wang et al., 2008; Pan et al., 2008; Merkin et 
al., 2012) and many other multicellular species have also been shown to feature AS (Stolc et al., 
2004). Moreover, contrary to the assumption that they lack alternative splicing entirely, single 
cell organisms have recently been discovered to feature a few genes that undergo AS (McGuire 
et al., 2008) thus pushing the estimated date for the origin of alternative splicing to the pre-
multicellular eukaryotes era (Irimia, Rukov, et al., 2007). Various types of AS exist including 
exon skipping, exon inclusion, alternative 5′ and 3′ ss activation, mutually exclusive exons and 
intron retention (figure 3). Of these, cassette exon (i.e. exon skipping or inclusion) is the most 
reported (and most studied) AS event whereas intron retention is the least. The effect of AS on 
protein production can be immense. The potential isoforms emerging from a single gene can be 
hundreds or thousands (Nilsen and Graveley, 2010) and it can have profound biological 
consequences, e.g. in Drosophila various alternative isoforms of the gene fru (fruitless) 
determine the sex (Demir and Dickson, 2005). Alternative splicing is not common in the U12 
genes. Of the few cases of alternative 5′ss, 3′ ss and exon skipping that has been reported, either 
their significance is not known or at least it is unknown whether the events are regulated or 
resulted from splicing errors (Zhu and Brendel, 2003; Chang et al., 2007; Lin et al., 2010). 
Additionally, there are a few examples where the major and minor introns/spliceosomes 
collaborate in mutually exclusive fashion. They allow the introns to be spliced either by the 
major or minor spliceosome in a tissue specific manner, e.g. JNK2 gene in mouse (Chang et al., 
2007), or prospero gene in D. melanogaster (Scamborova et al., 2004; Borah et al., 2009).
The regulation of AS (or in general splicing) is regulated by various sequence elements within 
pre-mRNA collectively known as splicing regulated elements. These elements are located in both
intronic and exonic locations and they provide binding sites for splicing factor (SF) proteins that 
function as either enhancers or inhibitors of intron/exon definition (reviewed by Wang and 
Burge, 2008). Predominantly common in the mammals, exon definition involves cross-exon 
interactions of splicing factors that bind near the 3′ ss upstream and 5′ ss downstream of the exon
(Robberson et al., 1990). Intron definition, however, involves cross-intron interactions of SFs 
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binding on the intron and near to its 5′ and 3′ ss (reviewed by Berget, 1995). It is common in 
plants, fungi and invertebrates. Two of the most studied classes of splicing regulatory elements 
are exonic splicing enhancers (ESE) and exonic splicing silencers (ESS) which are typically 
regulated by SR and  hnRNP protein families, respectively. An examples of how SFs can regulate
alternative splicing is when an exon is silenced due to inhibition, in addition to the possibility 
that the exon can be excluded from the mRNA (or skipped) alternative exons may find 
opportunity to be included yielding mutually exclusive exons, alternative 3′ ss or alternative 5′ ss
activation. Intron retention regulation is however more complex and is dependent on a 
combination of splicing factors and dedicated mRNA export factors (Reed and Cheng, 2005; 
Sakabe and De Souza, 2007; Wang and Burge, 2008). Interestingly, splicing factors are also 
known to be gene or location dependent, meaning that their function may vary or they may 
become inactive if their gene or location is changed. As an example some SR proteins promote 
splicing when bound to exonic sites but inhibit splicing when bound to the intronic sites 
(Kanopka et al., 1996; Ibrahim et al., 2005). The distance of the SR protein ESEs from the 
introns are also shown to affect their enhancing efficiency (Graveley et al., 1998). One 
interesting observation related to the differences between regulation of splicing of U12 and U2-
type introns is that due to the more restricted and conserved splice sites of the U12-type introns 
(1.1.2), the U12-type introns may be less dependent on external splicing factors (SFs) to undergo
accurate splicing in comparison to U2-type introns. This may also contribute to the fact that the 
U12-type introns are rarely alternatively spliced.
Figure 3. The main patterns of alternative splicing. The common exons are indicated with orange 
boxes. The exons involved in alternative splicing (the ones differing between isoforms) are shown 
with green boxes. The alternative splicing events are arranged above or beneath the horizontal lines, 
i.e. the reference introns.
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Splicing factors have been described as a selective force driving the evolution of the 
spliceosome. Some have even argued that the evolution of these proteins built the selective 
pressure under which constitutively spliced exons adapted to be able to splice alternatively (Ast, 
2004; Busch and Hertel, 2012). As an example, a binding of SR protein in the vicinity of an exon
(which is solely spliced constitutively) may cause negative selection to that exon and the 
surrounding splice sites, ultimately leading to weaker surrounding splice sites (due to 
accumulation of mutations over time) and alternative splicing adaptivity of the exon. Others 
however argue that accumulation of alternative splice sites near the introns (due to mutations and
weak negative selection) and maybe also weak intronic splice sites in the early spliceosomal 
introns (Irimia, Penny, et al., 2007) can promote the rise of alternative splicing (Keren et al., 
2010; Rogozin et al., 2012; Koonin et al., 2013). Whether the SR proteins played a significant 
role or not, in support of the idea that weak splice sites might be involved with the alternative 
splicing evolution, it has been reported that alternatively spliced exons indeed feature weaker 
splice sites compared to constitutively spliced exons (Stamm et al., 1994; Carmel et al., 2004; 
Sorek et al., 2004).
Features other than SFs also seem to be involved in the regulation of alternative splicing. In fact, 
various studies have attempted to discover various RNA features (noted as regulatory splicing 
codes) that are not only associated with the abundance of spliced isoforms but also can be used 
to predict the occurrence of various splicing events (Wang and Burge, 2008; Hallegger et al., 
2010; Barash et al., 2010). Note that similar to SFs, splicing code is also not specific to 
alternative splicing regulation, and is also involved in regulation of constitutive splicing (Black, 
2003; Fu, 2004) and may also determine whether an exon is alternatively or constitutively 
spliced (Barash et al., 2010). One particular study examined 1014 RNA features embedded in 
exons and their flanking introns and analyzed their effect on the probability of exon inclusion, 
skipping or no-change (i.e. neither inclusion nor skipping) in the transcripts across several 
samples (Barash et al., 2010). The features were grouped into 4 classes: previously reported or 
known motifs e.g. exoninc/introninc enhancers and silencers (i.e. 6-8 nucleotides long); novel 
motifs (i.e. 5-7 nucleotides long); short motifs (i.e. 1-3 nucleotides long); and features that 
describe the transcript structure. In order to properly address the tissue specificity of the 
alternative splicing events and the regulation of SFs the studied samples were also collected from
27 different mouse tissues. Various combination of features were evaluated based on the amount 
of information for which they accounted with regards to tissue-dependent splicing. Eventually, a 
combination of ~ 200 of the most significant RNA features were chosen to assemble a splicing 
code that can be used to predict inclusion/skipping of the exons. Interestingly, this assembled 
splicing code includes features from all 4 classes mentioned above, including features that are 
related to the structure of the transcripts e.g. intron/exon lengths, secondary structures and 
whether exon inclusion/exclusion introduces premature termination codons (PTC). Furthermore, 
excluding the RNA structural features from the splicing code leads to less accurate predictions, 
confirming their importance in regulation of alternative splicing (Barash et al., 2010) . 
1.2.1. Intron retention and intron detention
As mentioned above, intron retention (IR) is the least reported alternative splicing event in 
mammals, whereas in lower metazoans, fungi and protozoa it is the most common (Ner‐Gaon et
al., 2004; Keren et al., 2010; McGuire et al., 2008). Weak splice sites, small intron size, high GC
content and increase in density of few intron splicing enhancers i.e. ISEs such as GGG and a 
number of ESS regulators are reported to be associated with intron retention hence IR is usually 
attributed to poor or mis-splicing of the introns due to the weak splice sites or lack of exon/intron
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definition (Galante et al., 2004; Sakabe and De Souza, 2007; Amit et al., 2012). Furthermore, the
inefficient or slower splicing of introns such as conditions described for U12-dependent 
spliceosome has been reported to result in the retention of the introns (Patel et al., 2002; Pessa et
al., 2006). The retention of introns usually results in transcripts with large exons that include the 
retained introns and their flanking exons. Due to the inclusion of introns, mRNAs usually 
include one or more PTCs, which, if located farther than 50-55 nucleotides of an exon-exon 
junction it can trigger the degradation of transcripts by non-sense mediated mRNA decay (NMD)
(Popp and Maquat, 2013). Preventing the production of faulty and potentially harmful proteins, 
other IR transcripts are degraded by the exosome nuclear degradation (described in details in 
1.2.3), or they may be stable in the cell hence, also bearing the name “detained introns” (Boutz 
et al., 2015).
Although IR has mostly been described as hazardous to the cells and destined for degradation, 
recently various regulatory functions have been discovered for a number of these transcripts. In 
plants the majority of the IR transcripts are not susceptible to NMD despite the fact that most 
feature PTCs (Kalyna et al., 2012). Some IR transcripts may be post-transcriptionally spliced to 
increase the rate of protein production if needed. Examples of such regulatory functions of IRs 
has been seen both in plants e.g. Marsilea vestita (i.e. the hairy water clover) and animals e.g. 
Nematostella vectensis (i.e. the starlet sea anemone) (Boothby et al., 2013; Moran et al., 2008). 
In Drosophila the expression of the X chromosome gene msl-2 (i.e. male-specific lethal 2) is 
regulated by producing IR isoforms in females and spliced isoforms in the males (Zhou et al., 
1995; Bashaw and Baker, 1995). Using this strategy the X-linked gene can produce functional 
proteins in males only, i.e. dosage compensation. Furthermore, in animals IR is reported to be 
associated with detection of RNA by retrotransposons and also exclusion of exons (with flanking
retained introns regulated by hnRNPLL)  (Buckley et al., 2011; Cho et al., 2014). 
Finally, a number of IR mRNAs has also shown signs of protein production. One example is the 
production of a novel but truncated Cyclin D1b isoform as a consequence of retention of intron 
4, which is upregulated in prostate and esophageal cancers and promote cellular transformation 
activity as opposed to other isoforms of Cyclin D1 (Solomon et al., 2003; Comstock et al., 
2009). Another interesting case is IR of calcineurin gene (studied in mice) that produces CnAβ1 
isoform with improved functions comparing to the canonical isoform (Felkin et al., 2011). 
CnAβ1 plays a crucial role in myoblast proliferation and regeneration stimulation, and it is also 
reported to improve cardiac function (Felkin et al., 2011; Padrón-Barthe et al., 2018).
1.2.2. Cryptic splicing
In addition to the annotated splice sites in the genome of the eukaryotes, many other weaker and 
less active (or inactive) splice sites exist in genes that under some circumstances may become 
more active or even become the dominantly used splice site. Rather than being completely 
inactive in normal conditions, it is suggested that many of these cryptic splice sites are always 
active but at very low levels; hence, normally they are not easily detected (Kapustin et al., 2011).
It has also been shown that cryptic splice sites situated within the exonic regions of a gene in a 
species may be spliced under normal conditions in an orthologous gene in another species 
(Kapustin et al., 2011). Defective intron recognition caused by spliceosomal mutations can 
activate the cryptic splice sites upon mis-splicing of the original site. These conditions are 
usually seen in splicing diseases (Tazi et al., 2009; Verma et al., 2018). Cryptic splice sites often 
cause translational frame shifts which in turn may cause PTCs and as a result lead to degradation
of the mRNA by NMD. 
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In order to detect the cryptic splice sites in a sample, one strict and conservative approach is to 
consider all active splice sites that are absent form gene annotation databases such as RefSeq 
(Pruitt et al., 2007) or Ensembl (Zerbino et al., 2018). However due to the fact that many cryptic 
splice sites may be active in low levels under the normal conditions, one should also take into 
account the Ensembl/RefSeq annotated splice sites that are detected in low levels under normal 
conditions but are detected in high levels under the study conditions (e.g. splicing disease).
1.2.3. RNA degradation
Defective splicing of the introns or processing of mRNAs can lead to production of abnormal 
mRNAs. Subsequently, these aberrant mRNAs may lead to production of dysfunctional or 
harmful proteins. Various systems exist in the cell to degrade these mRNAs. RNA degradation 
may occur in cytoplasm or in the nucleus. The enzymes that are known to be involved are either 
endonucleases or exonucleases that cut RNAs internally, or from the 5′/3′ end respectively. 
Furthermore, the degradation proceeds either from 5′ to the 3′ of the mRNA or from 3′ to 5′ 
(reviewed by Houseley and Tollervey, 2009).
XRN2 exonuclease in mammals (i.e. Rat1p in yeasts) is an example of an enzyme that degrades 
in 5′→ 3′ direction in the nucleus. Only mRNAs that lack a 5′ cap are targeted by this 
exonuclease. Therefore most pre-mRNA transcripts that are capped with 7meG and bound by 
cap-binding complex are immune to this type of degradation. However, if the cap is removed by 
DCP2 decapping enzyme, for example during pol-II mediated transcription pausing, the resulting
cap-less mRNA is degraded and transcription is prematurely terminated by the XRN2 activity. 
More generally, XRN2 has a central role in transcription termination. In a widely-accepted 
model for transcription terminaton (so called 'torpedo model') transcription proceeds past the 
polyadenylation site of the mRNA. Cleavage of the primary transcript by the polyadenylation 
machinery creates an unprotected 5' end for transcripts extending downstream of the cleavage 
site. This serves an entry point for the Xrn2 exonuclease, which start to chase the transcribing 
pol-II. When XRN2 reaches the transcribing pol-II the polymerase is detached from the DNA 
template, leading to termination of transcription (Luo et al., 2006; Brannan et al., 2012). The 
XRN2 exonuclease is also reported to co-transcriptionally degrade the abnormally spliced 
transcripts in mammals (Davidson et al., 2012).
Nonsense mediated mRNA decay (NMD) is another mRNA degradation process that is known to 
occur in the cytoplasm. This pathway targets mRNAs that include PTCs. PTCs can result from, 
for example, nonsense or indel mutations, leading to frame shifts, cryptic splice site activation or
intron retention (Leeds et al., 1991; Lykke-Andersen et al., 2000). If the PTC is located prior to 
an exon junction complex and farther than 50-55 nucleotides from the complex, during 
translation the NMD pathway will be activated (Zhang et al., 1998; Le Hir et al., 2000). NMD is 
also involved in regulation of alternative splicing. Many RNAs that are subjected to alternative 
splicing may be detected and degraded by this degradation pathway (Lewis et al., 2003; Baek 
and Green, 2005). Many splicing factors (e.g. SR proteins) are also regulated in similar fashion, 
through a combination of alternative splicing and NMD (Lareau et al., 2007). Over-expression 
and protein-production for several genes (e.g. PTB) are also reported to be compensated by 
including more PTCs in their mRNA products, making them susceptible to NMD degradation 
(Wollerton et al., 2004). Furthermore, U1 and U11 snRNPs were both discovered to regulate 
their proteins using alternative splicing coupled with NMD (Rösel-Hillgärtner et al., 2013; 
Verbeeren et al., 2010). In the U1 regulation, activation of any of the three downstream 5′ ss in 
intron 7 of U1-70K activates a downstream 3′ ss. Regulated by U1C this leads to inclusion of a 
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PTC containing exon in the final mRNA products. Eventually these PTC containing mRNAs are 
detected and degraded by NMD which results in lack of functional U1-70K mRNAs and 
decreased protein levels. Due to requirement of both U1C and 70K for correct functioning of U1 
snRNP, the lack of 70K leads to decrease in detection of cryptic 5′ ss, eventually driving the AS 
balance back towards producing more functional 70K mRNAs (Rösel-Hillgärtner et al., 2013). 
Similarly the cellular levels of U11 snRNP are regulated through a tandem repeat of U12-
dependent 5′ ss known as the USSE that exist in the fourth intron of U11-48K gene (and in the 
3'UTR of U11/U12 65K). The U11-48K is known to be involved in the recognition of the 5′ ss of
U12-type introns (Turunen et al., 2008). Binding of U11 to USSE in 48K mRNA activates an 
upstream U2-dependent 3′ ss, causing frame-shift and PTC in the mRNA products (in 
comparison to the correctly spliced mRNA). This leads to detection and degradation of the 
alternatively spliced mRNAs by NMD and thus  decreased levels of the 48K mRNA and protein. 
The lack of 48K leads to decreased recognition of USSE, driving the AS balance to production of
more correctly spliced 48K mRNAs (Verbeeren et al., 2010). 
The exosome is a multi-protein complex active in the nucleolus, nucleus and cytoplasm of 
eukaryotes. It is constructed of 9 core subunits in the shape of a barrel. Six of the subunits are 
arranged to form a ring (i.e. Rrp41, Rrp45, Rrp46, Rrp43, Mtr3 and Rrp42) whereas 3 other 
proteins (i.e. Csl4, Rrp4 and Rrp40) form a cap on the side of the ring (Makino et al., 2013). The 
catalytic/ribonuclease activities are carried out by subunits Rrp6 (i.e. PM/SCL-100 in 
mammalian system) and Dis3 (i.e. Rrp44) (Liu et al., 2006; Dziembowski et al., 2007). 
Furthermore, two paralogs of Dis3 are known in humans i.e. Dis3L1 which is associated with the
exosome core, and Dis3L2 which is not associated (Staals et al., 2010; Tomecki et al., 2010; 
Astuti et al., 2012). The two proteins Dis3L1 and RRP6 are exoRNases and degrade RNA in 
3ʹ→ 5ʹ direction, while Dis3 degrades RNA from 3ʹ to 5ʹ in both exonucleolytic and 
endonucleolytic manner (Lebreton et al., 2008). Contrary to Dis3 which is mainly nuclear, 
Dis3L1/L2 are active in the cytoplasm (Tomecki et al., 2010; Malecki et al., 2013). Exosome is 
also involved in various other pathways such as maturation of several ncRNAs (e.g. rRNA, 
snRNA and snoRNAs) and mRNA quality control through regulation of NMD, non-stop decay 
(i.e. RNAs lacking termination codon) and no-go decay (i.e. ribosomal stalling during 
translation) (reviewed by Chlebowski et al., 2013).
Finally, one of the strategies for RNA quality control and prevention of coding of the truncated 
mRNAs is detention of these mRNAs in the nucleus (reviewed by Schmid and Jensen, 2010; 
discussed in more detail in 1.2.1). 
1.2.4. U12-type introns and diseases
Several diseases have been discovered that were caused  by mutations in U12-dependent 
spliceosome, namely IGHD, MDS, EOCA, MOPD1/TALS, RFMN and LWS (table 2). All of 
these diseases are known to feature increased levels of the retention of U12-type introns; while 
other splicing defects, e.g. cryptic 5′ ss or 3′ ss activation, have been recognized in some of these
diseases. Despite these reported abnormal splicings, correctly spliced mRNAs are also detected 
in all patients, hence the disease causing mutations are described as hypomorphic. These 
mutations  lead to decreased levels (rather than the absence) of correctly spliced mRNA products
(reviewed by Verma et al., 2018).
IGHD is characterized by pituitary hypoplasia and a consequent lack of growth hormone. The 
form of this disease associated with minor spliceosome is caused by recessive mutations in the 
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RNPC3, i.e. a gene that codes for U11/U12-65K protein. The disease-causing mutations are 
compound heterozygous. In particular, they include one missense mutation i.e. P474T together 
with one of the two nonsense mutations R502X or R205X. The P474T and R502X mutations are 
located on the C-terminal of the RNA recognition motif (RRM) of 65K protein while the R205X 
is in its proline-rich region, situated between the two RRMs (figure 4A). The 65K protein is 
known to be involved in the U11/U12 di-snRNP formation (1.1.3). Another disease that has been 
associated with defective U12-dependent spliceosome protein component is MDS, i.e. a disease 
characterized by inefficient hematopoiesis and acute myeloid leukemia in extreme cases.  
Somatic mutations in various genes coding for splicing factors e.g.U2AF1, ZRSR2, SRSF2 and 
SF3B1 have been associated with MDS (reviewed by Inoue et al., 2016; Saez et al., 2017). 
Usually mutations in only one of the mentioned splicing factors has been detected in each 
patient; however, this mutation usually occurs together with mutations in other genes that code 
for epigenetic factors and cell signaling/transcriptional regulators (Mian et al., 2013). Here I 
focus on the MDS disease that is caused by mutations in ZRSR2/Urp which code for a protein 
involved in the recognition of 3′ss of U12-type introns (Madan et al., 2015). These mutations 
include a wide-spread nonsense, missense, frameshift and splice site mutation which are 
scattered across the gene (figure 4D). Both increase of retention of U12-type introns and 
activation of cryptic U2-dependent splice sites has been reported in the MDS patients that were 
diagnosed with mutation in ZRSR2 (Madan et al., 2015). Both MDS and IGHD will be discussed
in further details later (4.4).
The only presently known disease to be caused by mutations in the U12 snRNA gene (RNU12) is
EOCA. It is characterized by defects in muscle coordination due to cerebellar hypoplasia and 
degeneration. Many patients also suffer from hypotonia in infancy, learning difficulties, seizures 
(febrile or complex partial), delayed motor skills. A 84C > T (homozygous) mutation in RNU12 
has been detected in a group of studied EOCA patients (figure 4B; Elsaid et al., 2017). However, 
mechanistic details on how this mutation disrupts the function of the minor spliceosome is not 
exactly known at the moment. Both increased retention of U12-type introns and upregulation of 
U12 was detected in patient cells; however, no activation of cryptic splice sites were reported.
Finally, MOPD1/TALS, RFMN and LWS are 3 diseases known to be caused by defects in 
RNU4ATAC (figure 4C). As mentioned previously, U4atac snRNA joins U6atac and U5 to form a
U4atac/U6atac.U5  tri-snRNP which enters the nascent spliceosome after the 5′ ss and 3′ ss are 
detected by the U11/U12 di-snRNP (1.1.3). The first out of the 3 mentioned diseases associated 
with defective RNU4ATAC (MOPD1/TALS) is a rare autosomal recessive disorder; meaning that 
the disease is developed only if both copies of the RNU4ATAC gene are mutated (He et al., 2011;
Edery et al., 2011).  In its extreme form, it is characterized by postnatal growth retardation, 
developmental defects, and microcephaly. The patients usually do not survive beyond 3 years 
after birth. Most mutations that cause the severe forms of MOPD1/TALS are located in the 5′ 
stemloop of U4atac snRNA (figure 4C). This region contains binding sites of several proteins, 
including 15.5 K (Snu13) and PRPF31, both of which are crucial for the correct functioning of 
U5 (i.e. forming U4atac/U6atac.U5 tri-snRNP) (Makarova et al., 2002). The second disease 
(RFMN) is characterized by defects in growth, facial dysmorphia, cognitive delays and antibody 
deficiency. All reported cases of RFMN featured compound heterozygous mutations in 
RNU4ATAC, while the most severe cases of the disease shared one mutation with MOPD1/TALS
(figure 4C). Other mutations associated with this disease are mainly located on stem II of 
U4atac/U6atac snRNA complex, with one case featuring mutation in the sm-site (figure 4C). 
Another autosomal recessive disease associated with defective RNU4ATAC is LWS. Mutations in
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5′ and 3′ stemloops of the U4atac snRNA are shared with MOPD1/TALS, together with a 
mutation in the stem II of the U4atac/U6atac are associated with LWS. LWS is characterized 
with epiphyseal dysplasia and microcephaly; however, the symptoms are mild in comparison to 
TALS/MOPD1. Note that increase of retention of U12-type introns have been reported in 
MOPD1/TALS and RFMN patients but currently not in the LWS patients (He et al., 2011; Edery 
et al., 2011; Merico et al., 2015). This may be due to lack of transcriptome analysis (Farach et 
al., 2018). However judging on the many RNU4ATAC mutations in common between the 2 
diseases (MOPD1/TALS and RFMN) and LWS (figure 4C) it would not be unexpected if similar 
to the two, LWS also features an increase of retention of U12-type introns. The wide range of 
splicing defects observed in diseases caused by defective U12-dependent spliceosome highlight 
the importance of suitable tools to be able to detect these splicing abnormalities, which is 
discussed in the following.
Defective component Abbreviation Disease name
U11/U12-65K (RNPC3) IGHD Isolated Growth Hormone Deficiency (III)
ZRSR2 MDS Myelodysplastic Syndrome (Madan et al., 2015)




Microcephalic osteodysplastic primordial dwarfism/ 
Taybi-Linder Syndrome (Edery et al., 2011; He et al., 
2011)
RNU4ATAC RFMN Roifman syndrome (Merico et al., 2015)
RNU4ATAC LWS Lowry Wood syndrome (Farach et al., 2018)
Table 2. Human diseases caused by defective minor spliceosome (adapted from Verma et al., 2018).
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Figure 4. Mutations in various snRNA and protein components of U12-Dependent spliceosome that 
are associated with known diseases (adapted from Verma et al., 2018), including the recently 
reported Lowry wood syndrome (Farach et al., 2018). A) U11/U12-65K protein and the location of 
IGHD associated mutations. B) secondary structure of U12 snRNA and the location of the EOCA 
associated mutation. C) Secondary structure of U4atac snRNA and the location of MOPDI/TALS, 
RFMN and LWS associated mutations. D) ZRSR2 protein and the location of MDS associated 
mutations. Note that the 51G > A mutation in U4atac (C) has been identified  in each of the three 
diseases TALS, RFMN and LWS whereas the 46G > A mutation is present in the two diseases 
MOPD1/TALS and LWS, and the 5A > C mutation is specific to the LWS disease only.
1.3. Bioinformatics methods for analyzing pre-mRNA splicing
Several bioinformatics methods have been described in details that are extremely useful to carry 
out various genome-wide splicing/transcriptome analysis such as: identification, detection and 
quantification of various expressed isoforms in the studied samples; detection of differentially 
expressed genes/isoforms (DEG) across several samples; IR abundance level estimation in a 
sample; discovery of significantly differentially retained introns across several samples; and 
discovery of U12- and U2-type introns within genes. Comparison of various RNAseq platforms 
and software that carry out mapping of the sequencing reads to the genome/mRNAs, however, is 
beyond the scope of this thesis (for a comprehensive review see Engström et al., 2013; Li et al., 
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1.3.1. Genome-wide transcriptome analysis using RNAseq data
Genes in many species, including a number of known single cell organisms undergo alternative 
splicing (1.2). Furthermore, in mammalian genes it has been discovered that the majority of the 
genes (i.e. >95% in human) undergo alternative splicing (Pan et al., 2008; Merkin et al., 2012). 
The occurrence of these events are regulated by splicing factors, many of which exhibit 
tissue/cell/developmental-stage specific activities that results in different alternative splicing 
events and gene expression abundance across various samples (Yeo et al., 2004; Castle et al., 
2008; Grosso et al., 2008). The generality of alternative splicing highlights the importance of 
detection of different isoforms and quantification of the isoform levels. Such information can be 
helpful to understand the biological pathways and mechanisms that are associated with various 
phenotypes such as progression of a disease (Costa et al., 2013). Several analysis methods are of 
interest when studying the transcriptome; namely identification of the expressed isoforms 
including novel isoforms that previously were not discovered; detection of genes and isoforms, 
i.e. whether they are expressed or not; quantification of isoforms; and differential expression of 
the isoforms (Angelini et al., 2014). Many of the existing software tools tackle these challenges 
independently, making determination of a best performing method complicated since it requires 
one to consider all different combinations of the individual tools and their various parameter 
settings. 
1.3.2. Identification,detection and quantification of expressed isoforms 
using RNAseq data
One of the main questions in RNAseq data analysis is the identity of the isoforms and their 
relative expression levels in the studied sample. To address this, a number of recent studies have 
focused on the available software that carry out three main analyses, i.e. identification, detection 
and quantification of all expressed isoforms. These studies also attempted to evaluate and 
compare the methods that carry out these analysis  (Steijger et al., 2013; Angelini et al., 2014). 
One study (Angelini et al., 2014) evaluated several of these software, including the popular 
Cufflinks (Trapnell et al., 2010) which is part of the Tuxedo analysis pipeline  (Trapnell et al., 
2012), by employing several simulated data constructed of either paired-end or single reads of 
various lengths. Their analysis were carried out under three modes: quantifying isoforms strictly 
and solely from a predefined annotated set of isoforms; incorporating predefined annotated 
isoforms to build novel isoforms and then quantifying the new set of isoforms which also 
includes the novel isoforms; and finally building all isoforms de novo while considering no prior 
knowledge of the possible isoforms and then quantifying the built isoforms. 
The available isoform detection/quantification software were overall more successful when they 
took into account the known isoform annotations either during mapping of the reads to the 
genome or when detecting the expressed isoforms. This success was however, specific to 
detection of the high and moderately expressed isoforms since none of the studied methods were 
able to accurately detect the low expressed isoforms (Angelini et al., 2014).  Furthermore, 
despite the fact that increasing the read length and sequencing depth can improve the results, 
neither completely resolves the detection problem with the low expressed isoforms. In fact, there
seems to be a saturation point for the read depth that once reached, ceases to improve the 
accuracy but rather leads to discovering more false positives (Angelini et al., 2014). 
Apart from detection of the isoforms, discovery of their true expression abundance is even more 
difficult and prone to errors (Steijger et al., 2013; Angelini et al., 2014). To complicate the 
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situation even more, alternative splicing complexity of higher eukaryotes such as humans 
imposes further limitations on the performance of the isoform detection and quantification 
software (Steijger et al., 2013). To overcome this limitation it has been suggested that 
incorporating biological replicates may be a solution to improve the accuracy of detection and 
quantification of the expressed isoforms (Vardhanabhuti et al., 2013; Steijger et al., 2013). 
Studies show that there remains space for further improvements both on the technical level e.g. 
adaptation of sequencing platforms that use long reads, and in the analysis methods e.g. 
incorporating biological replicates to improve detection and quantification of the isoforms 
(Steijger et al., 2013; Angelini et al., 2014).  
1.3.3. Discovery of differentially expressed genes using RNAseq data
In biological studies, apart from detecting and quantifying the expressed isoforms in the samples,
detecting genes/isoforms that are differentially expressed across several studied samples are also 
of interest. In this regard several recent studies have attempted to evaluate the various available 
differential expression analysis tools and compare them to one another (Soneson and Delorenzi, 
2013; Rapaport et al., 2013; Tang et al., 2015). Here I will describe a brief summary of their 
findings.
First, several studies have demonstrated that due to the different normalization and algorithms 
used to detect the differentially expressed genes (DEG), different methods/algorithms (e.g. 
IntEREst and DESeq) report substantially different number of DEGs (Rapaport et al., 2013; Tang
et al., 2015). Reassuringly, the popular methods that are frequently used for DEG discovery in 
RNAseq data i.e. edgeR and DESeq overall perform very well, especially under the conditions 
where biological replication is limited i.e. < 3 (Robinson et al., 2010; Anders and Huber, 2010; 
Love et al., 2014; Soneson and Delorenzi, 2013). However, Limma that was originally 
developed for microarray analysis (but were recently adjusted to analyze RNASeq data) perform 
as well as edgeR or DESeq, especially for data with large numbers of biological replicates  
(Ritchie et al., 2015). This is surprising since Limma assumes that the data is normally 
distributed, which may be reasonable for microarray data but does not apply to RNAseq data (Di 
et al., 2011). For DEG discovery in a more complicated setting e.g. among a larger number of 
groups of samples, edgeR and DESeq outperform Limma (Tang et al., 2015).  
In RNAseq data, the read counts assigned to individual genes are described to follow a Poisson 
distribution across the technical replicates of a sample, while they follow an over-dispersed 
Poisson such as negative binomial (NB) across biological replicates (Marioni et al., 2008; Di et 
al., 2011). This over-dispersion arises from the fact that the variance of the expression of genes 
across multiple samples is larger than their mean expression (Robinson and Smyth, 2007; Di et 
al., 2011). To model for the dispersion, methods such as edgeR and DESeq assume dependency 
of the variance ν to the mean μ by considering a ν = μ + α μ2 relationship where α is the 
dispersion factor that can be estimated from the data. However, judging on the surprisingly good 
performance of Limma in detecting DEGs in RNAseq data, it is suggested that for a large 
enough data set with a large number of genes (and more than 3 biological replicates) accurate 
modeling of the variance may be more important than the discreteness in the data (Rapaport et 
al., 2013). The normalization used by various methods can also heavily influence the final 
discovered DEG results (reviewed and benchmarked by Dillies et al., 2013). For instance, edgeR
uses trimmed mean of m values (TMM) where it assumes that most genes are not differentially 
expressed across the samples. It initially filters the genes that were not expressed across any of 
the samples and later also removes the genes showing the most extreme (high/low) expressions 
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in each sample. Subsequently, edgeR chooses one sample as the reference and scale all the other 
samples to the reference by measuring the weighted mean of log ratios of the expression values. 
The scaled values are eventually centered to 1 (Robinson and Oshlack, 2010). DESeq also 
assumes that most genes are not differentially expressed across the samples. The normalization 
in DESeq is carried out according to scaling factors measured for each sample. Each scaling 
factor is measured by the median of log ratio of expression levels of the genes to the geometric 
mean of the expression of the genes across all samples, while excluding all genes that are not 
expressed in one or more samples (Anders and Huber, 2010).
Finally, evaluations of DEG analysis software using simulated data suggests that methods show 
improved performance if the following conditions apply: in comparisons with two groups of 
samples, one group features symmetric changes of gene expression levels (i.e. both up and 
down-regulated genes rather than solely up-regulated genes); and in comparisons of several 
groups (e.g. G1, G2 and G3) every group features significantly differentially expressed genes 
compared to the other group with an overall rising/decreasing order e.g. G1<G2<G3 or 
G2<G1<G3 (Soneson and Delorenzi, 2013; Tang et al., 2015). It is notable that expanding the 
comparison of 2 groups of samples to 3 in the evaluation of DEG discovery software better 
outlines the differences in performance of these tools and explains the popularity of RNAseq 
specific methods e.g. DESeq and edgeR over the methods originally developed for microarray 
analysis e.g. Limma (Tang et al., 2015). This shows that in order to better understand the 
advantages and disadvantages of various DEG discovery methods they should also be evaluated 
under more complex settings and design experiments that consists of more than a comparison of 
2 groups of samples; i.e. a criteria that future comparison studies may take into account.
1.3.4. Estimation of IR abundance and differential IR analysis
Conditions that can lead to poor splicing or mis-splicing of the introns e.g. weak splice sites, 
small introns, high GC content and etc. together with slower/inefficient splicing of the introns 
can lead to their retention (1.2.1). Transcripts that contain retained introns are usually destined to
degradation, regulatory functions and in some cases protein production (1.2.1). Therefore, 
discovery of transcripts with retained introns in a sample or  identifying those featuring 
significantly differential intron retention (IR) across several studied samples are of potential 
interest. In fact, many previously described isoform reconstruction and detection methods (1.3.3)
can be applied to detect intron-containing isoforms. Subsequently, these built isoforms can also 
be used to detect the transcripts with significantly differential IRs across several samples by 
running various well known DEG discovery methods e.g. DESeq, edgeR, Cuffdiff (1.3.4). While
it is already a challenging task to accurately detect and quantify various isoforms in a sample 
(1.3.3), detecting/quantifying isoforms with retained introns has proven to be even more difficult 
(Steijger et al., 2013; Vanichkina et al., 2018).  This is attributed to several particular 
characteristics of introns and IR transcripts: introns are normally much larger in length compared
to exons; hence, they require much more sequencing reads to fully cover their length (i.e. 
conditions usually not met by biological studies performing RNAseq); introns feature more 
repetitive sequence elements i.e. regions to which a small number of reads may be mapped 
accurately (by the mapping software) due to uncertainties caused by multi-mapping reads; some 
introns feature non-coding RNAs (e.g. miRNAs or snoRNAs) which, if expressed, may influence
the read-counts of those introns; the detection of IR isoforms requires excessive sequencing 
depth if they are less expressed compared to their spliced counterparts i.e. isoforms lacking 
introns entirely (Vanichkina et al., 2018).
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To resolve the shortcomings of the available isoform analysis software in detecting, quantifying 
and differential expression analysis of IR isoforms, recently a number of dedicated software tools
have been developed that specifically analyze these isoforms, e.g. IRFinder and KMA 
(Middleton et al., 2017; Pimentel et al., 2016). As for instance, the IRFinder measures the 
intronic abundance (i.e. the number of reads that map to the intron) and exonic abundance (i.e. 
the sum of the intron-spanning reads that partially mapping to the upstream and downstream 
exons). It measures the IR ratio for each intron, i.e. relative intronic abundance over the sum of 
intronic abundance and exonic abundance. Furthermore, it excludes intronic regions that overlap 
the reference features (provided by users as a GTF file) and introns with radically high and low 
IR ratio. The differentially retained introns are discovered by analyzing IR ratio changes using 
other methods such as DESeq2 (Love et al., 2014). The existing methods however do not 
completely resolve all the issues with detecting the IR isoforms that we mentioned above. This 
leaves room for development of methods for improved IR detection, quantification and 
differential analysis.
1.3.5. Computational detection of U2 and U12-type introns
Two classes of introns have been discovered in the eukaryotes i.e. denoted either as U12- or U2-
type introns (1.1.2). Furthermore, two subtypes of U12-type introns have been described to date, 
the GT-AG variant (with initial GT and terminal AG di-nucleotides) and the AT-AC variant. Both
GT-AG and AT-AC terminal dinucleotides are however found in U2-type introns as well  
(Dietrich et al., 1997);  hence, additional sequence information other than the initial and terminal
di-nucleotides should be taken to account in order to be able to distinguish between U12- and 
U2-type introns. Traditionally, consensus sequences were built and applied to detect the two 
intron types. In fact, this lead to the realization that the splice site patterns for the U12-type 
introns were more constrained than those of the U2-type (Dietrich et al., 1997; Sharp and Burge, 
1997).  Upon discovery of an increasing number of U12-type introns across the eukaryotic 
lineages the usage of position weight matrices (PWM), also known as position-specific scoring 
matrix (PSSM), for detecting U12-type introns became more popular (Staden, 1984; Burge et al.,
1998; Levine and Durbin, 2001; Zhu and Brendel, 2003). PWM is a two dimensional array with 
one dimension corresponding to the nucleotides (A, C, G and T) and the other dimension 
corresponding to positions (e.g. within splice sites of the introns); each value in the array 
represent a score describing the probability of finding a nucleotide (or amino acid) at a position. 
PWM was first introduced and applied to detect ribosome binding sites which define the 
translational initiation sites in the genes (Stormo et al., 1982). Using PWMs over consensus 
sequences is advantageous as it allows incorporation of information related to the probability of 
observing different variants in each position (Staden, 1984). In later studies, splicing donor, 
branch-point and acceptor PWMs were constructed by measuring logarithm (in base 2) of 
probability of each nucleotide occurring at a position in the corresponding U12/U2-dependent 
splice site (box1, formula 3; Staden, 1984; Levine and Durbin, 2001). To estimate these 
probability values, the number of each nucleotide in each position across several aligned 
sequences (i.e. splice sites of a group of known U2/U12-type introns) were counted and then 
divided to the number of sequences (box 1, formula 1 and 2). Based on the PWMs match scores 
were generated for donor/branch-point/acceptor sites of the U2 and U12-type introns (box 1, 
formula 4). This includes checking the nucleotides within each splice site individually and 
looking up the log2-probability of observing the nucleotide at the corresponding position from 
the PWMs, and eventually summing the extracted log2-probability values (box 1, formula 4). 
Eventually, threshold cutoffs for donor/branch-point/acceptor match scores were applied to 
classify each intron as either U2 or U12-type (Staden, 1984; Levine and Durbin, 2001; Alioto, 
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2007).  As an alternative to measuring these 3 match scores separately (corresponding to the 
donor, branch-point and acceptor sites), other studies have measured a pair of log odds ratios to 
detect whether an intronic sequence is U2 or U12-type. These values correspond to the relative 
probability that the sequence matches the 5′ ss (or respectively 3′ ss) of U12-type introns over 
the probability that the same sequence matches the 5′ ss (or respectively 3′ ss) of U2-type introns
(Burge et al., 1998; Zhu and Brendel, 2003). Furthermore, several other studies have converted 
the PWMs to log-odds matrices before they used them for scoring the splice sites of the introns. 
The conversion is carried out by taking the logarithm (base 2) of the relative probabilities at each
position of the PWM against a background probability, e.g. uniform probability of 0.25 for each 
nucleotide (Wasserman and Sandelin, 2004; Sheth et al., 2006; Madan et al., 2015; Merico et al.,
2015). Note that when generating the PWM, in order to avoid overfitting and complications 
caused by calculating the logarithm of zero many studies replace zero with a low pseudo-count 
value in the PWM when a nucleotide is completely absent from a position in the studied 
sequences (Burge et al., 1998; Wasserman and Sandelin, 2004; Sheth et al., 2006).  Various 
methods adapted by the mentioned studies, and also the completion of the genome annotations 
have yielded reports stating different number of U12-type introns for the same species, e.g. 
human. A relatively recent study that adapted in comparison a less strict and more inclusive 
method of detecting U12-type introns discovered 744 unique U12-type introns within the human 
genome, i.e. GRCh37 (hg19) assembly (Merico et al., 2015). This study focused on the 5′ ss and 
the branch point nucleotide sequences of the introns only to build PWMs and discover novel 
U12-type introns. They also excluded the initial di-nucleotides of the 5′ ss since these bases are 
highly conserved in U12-type introns (i.e. either GT or AT).
Detecting the U12-type introns allows comparing various features of these introns to the more 
common U2-type introns. Moreover, it is the first step in studying the mechanistic differences in 




Presuming that f (b , i) is the frequency of observing nucleotide b (i.e. either A,C,G or T) at 
position i across N aligned sequences of size k, the probability of observing nucleotide b at 
position i of the aligned sequences is p(b , i) and is calculated by the following formula:
Regular probability calculation: p(b , i)=
f (b , i)
N
.         (1)
For an efficient computation, often the logarithm of the probability is used. To avoid obtaining 
null values (logarithm of zero), the p(b , i) formula can be corrected using pseudo counts.
Corrected probability:  p(b , i)=
f (b , i)+s(b)
N+ ∑
b ' ∈{A, C ,G, T }
s (b ')
.    (2)
* s ( ) is the pseudo count function. 
**Assuming that the length of the input sequences is k, i={1,2,3,... , k } .
Each element of the PWM represents a weight score for observing nucleotide b at position i and
is shown here with W (b ,i) .
PWM construction:  W (b ,i)=log2
p(b , i)
p (b)
.                      (3)
* p(b) is the background probability of base b, usually replaced with 0.25 .
To score sequence S=s1s2s3...sk according to the PWM (i.e. W (b ,i) matrix) formula 4 can be 
used.
Evaluation of a given sequence:   E(S)=∑
i=1
k
W (si ,i) .      (4)
The information content in position i (in bits) is shown here with Bi and can be calculated as 
following:
Information content estimation: B i=2+∑
b
p(b ,i) log2 p(b ,i) .
Box 1.  Formulas used for constructing  PWMs, evaluating sequences based on PWMs and 
estimating the information content of each position of the aligned sequences e.g. splice sites 
(Wasserman and Sandelin, 2004).
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2. Aims of the study
In response to the growing interest to study intron retention (IR) events and attempting to 
overcome various technical difficulties that are known in detecting these events, this thesis 
initially presents Intron-Exon Retention Estimator i.e. IntEREst (I). IntEREst is an 
R/Bioconductor package that can be used for detection, quantification and differential analysis of
IR levels across various samples (I). The software also supports tools to detect the U12- and U2-
type introns based on their splice-site sequences. Furthermore, it supports comparison of 
retention levels of various subclasses of introns (e.g. U12-type introns vs U2-type). Taking 
advantage of these 2 options the retention levels of the U12-type introns are compared to that of 
the U2-type introns across 8 MDS patients with mutations in their ZRSR2 genes and 8 controls 
(i.e. 4 healthy individuals and 4 patients lacking the ZRSR2 mutation). We hypothesize higher 
retention of U12-type introns compared to U2-type in all samples due to the less efficient U12-
dependent splicing (in comparison to U2-dependent), and exacerbation of the IR of U12-type 
introns (compared to that of U2-type introns) as a consequence of defective splicing of U12-type 
introns caused by ZRSR2 mutations. The same results were expected to be acquired when 
analyzing a Maize data set consisting of 6 samples (3 roots and 3 shoots) featuring mutations in 
RGH3 (i.e. an ortholog of human ZRSR2) and 6 samples that lack this mutation: An 
approximately 2 fold higher retention of U12-type introns compared to U2-type in all samples 
and the retention increase of U12-type introns for samples with defective RGH3. 
In the second study, using an early version of the IntEREst software the long-time speculation 
that the U12-type introns are spliced less efficiently than the U2-type introns was investigated by
comparing the genome-wide retention levels of the U12-type introns to that of U2-type introns 
(II) . Both nuclear and cytoplasmic extracts from HeLa cells were studied, each under 3 
conditions :  knockdown of RRP41 subunit of the exosome, knockdown of DIS3 subunit of the 
exosome and control. We expect genome-wide increased IR for U12-type introns compared to 
U2-type introns, with a more prominent effect to be observed in the nuclear samples with KD of 
exosome subunits. We also hypothesize that transcripts containing unspliced U12-type introns 
are preferentially detected and degraded by the exosome in the nucleus.
Finally, various splicing abnormalities including activation of cryptic U2-dependent splice-sites 
and increased retention of U12-type introns are seen in the cells from three sisters that were 
diagnosed with isolated growth hormone deficiency (IGHD) and pituitary hypoplasia caused by 
defective U11/U12-65K (III). The molecular basis of the disease are studied thoroughly in 
relation to the splicing abnormalities that are caused by defective 65K, a protein that is known to 
be involved in U11/U12 di-snRNP formation. These discovered mechanisms show that a defect 
in minor spliceosome component can lead to tissue specific consequences, through leading to 
abnormal splicing patterns in the genes containing U12-type introns. 
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*BA: Differential alternative splicing ✓ ✓ ✓
BA: Differential expression gene ✓ ✓
BA: Intron retention (detection, quantification 
and statistical differential analysis)
✓ ✓ ✓
BA: RNAseq data analysis (e.g. read alignment
and normalization) 
✓ ✓ ✓
BA: U12-type intron annotation ✓ ✓ ✓
Cell fractionation ✓
Cell lines and cell culture ✓
Northern blot ✓ ✓
Protein over-expression in mammals ✓
Quantitative PCR ✓
RNA sequencing ✓ ✓




Western blot ✓ ✓
Table 3: Methods used in the publications. *BA stands for bioinformatics analysis.
In addition to the methods mentioned in tables 3, the following statistical tests have also been 
applied in this work :
Ordered alternative hypothesis tests are used to infer whether an order exist among two or more 
groups of IR values (I and II). The methods commonly used for theses tests are Kruskal Wallis 
and Jonckeere Terpstra (Kruskal and Wallis, 1952; Jonckheere, 1954). Both of these methods are 
non-parametric and as null hypothesis presume the medians of the compared groups of values to 
be equal. The alternative hypothesis for which the statistical test is used is that an increasing/ 
decreasing order exists among the compared groups of values. The latter method (i.e. Jonckheere
Terpstra) is used in the publications (I and II) of this thesis, since contrary to the former (i.e. 
Kruskal Wallis) it can consider a priori order across the groups of IR values and tests whether 
the analyzed groups of IR values follow this particular order.
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Enrichment analysis tests are commonly used to discover functions/pathways that may be 
associated with gene lists extracted from differential gene expression or other bioinformatics 
analyses. A simple and commonly used approach is to apply statistical methods such as Fisher's 
exact test, Hypergeometric distribution, Binomial probability and etc. to obtain p-values that 
indicate the probability that equal/more number of genes within the list may hit the feature 
randomly (II; Reviewed by Huang et al., 2009). The same statistical methods can also be used to 
test whether two different subsets of genes (e.g. genes with highly retained introns in two 
separate samples) significantly overlap (II).
Differential expression analysis tools detect the genes, transcripts or exons that are significantly 
differentially expressed across several samples (Rapaport et al., 2013; Tang et al., 2015). These 
methods apply various normalization (1.3.3) and statistical tests to detect the significantly 
differentially expressed genes. The two commonly used methods edgeR and DESeq apply either 
Fisher’s exact test or Likelihood ratio test to estimate p-values. In contrast, the DESeq2 method 
supports Wald and Likelihood ratio tests, while DEXSeq applies the Likelihood-ratio test to 
analyze differential exon usage (Robinson et al., 2010; Anders and Huber, 2010; Love et al., 
2014; Anders et al., 2012; Reyes et al., 2013). The p-values are based on the null hypothesis that 
when comparing controls to the treatment samples, differences observed in the expression of the 
genes are disregarding of the treatment and follow a Negative Binomial distribution (as 
expected) across the samples. The Wald test supported by DESeq2 (I), Likelihood ratio test of 
edgeR (I), Fisher’s exact test of edgeR (II) and the Likelihood ratio test of DEXSeq (I) have been
used in the publications of this thesis.
28
4. Results and discussions
4. Results and discussions
4.1. Development of an intron retention (IR) analysis tool
IR is the least studied alternative splicing event in mammals (1.2; 1.2.1). It is mainly caused by 
conditions such as weak splice sites, small size introns and is known to play a crucial role in 
RNA processing of plants, fungi and protozoa (1.2.1). Moreover, defects in spliceosome 
machinery can result in mis-splicing of the introns and their retention in the mRNA products, i.e. 
one of the main features of human spliceosomal diseases such as MOPD1/TALS (1.2.4). For 
these reasons the usefulness of a suitable dedicated intron retention analysis tool is imperative. In
this regard, due to the fact that specialized computational tools to study IR events have only 
recently become available (1.3.4; 4.6), previous analysis of IR were performed using either 
custom developed software pipelines  (Madan et al., 2015)  or publicly available general 
transcriptome assembly/abundance measurement software such as Cufflinks  (Trapnell et al., 
2010). IR analysis has proven to be a difficult task especially using conventional isoform 
detection software (1.3.4). In this respect, a custom software pipeline called IntEREst (Intron-
Exon Retention Estimator) was developed using R programming language to enable accurate 
detection of IR and comparison of IR levels across several samples (I). IntEREst also provides 
tools to detect U12-type and U2-type introns within the genome. This allows comparing of the 
retention levels of U12-type introns to that of U2-type introns at a genome-wide scale.
During the process of developing IntEREst, I initially formulated a custom pipeline to measure 
the retention levels of U12-type introns and compared them to U2-type introns at genome-wide 
scale using R programming language (II). In this initial version of IntEREst, the IR differential 
analysis were solely based on the reads that mapped to introns or intron-exon junctions. The 
reason for this was that we were initially using older RNAseq technologies that provided short 
sequence reads; e.g. SOLiD4 sequencing with 50 bps on positive and 35 bps on the negative 
strand (II). Furthermore, virtually no reads were mapped to the exon-exon junctions upon 
running the exon-exon junction mapping analysis software of SoLiD Bioscope. Therefore, the 
pipeline used only the intron mapping reads to determine the IR levels, estimate the FPKM 
normalized read counts and run comparison analysis to extract the introns with the most IR 
increase/decrease. For the differential IR analysis the edgeR package of R/Bioconductor was 
applied (Robinson et al., 2010). Further improvements on the IR analysis pipeline resulted to the 
development of the present R-Bioconductor package of IntEREst (I).
The present version of IntEREst uses, in addition to intron mapping reads, also the exon-exon 
junction or intron-spanning reads (based on configurations set by the user) to detect the 
differentially retained introns. The read counts of the introns/exons are then used (together with 
sample annotation information) to detect the significantly higher or lower retained introns using 
one of the multiple IR differential analysis modules supported by IntEREst (4.5). The package 
also incorporates and recognizes standard R/Bioconductor objects such as Summarized-
Experiment. IntEREst includes two read summarization functions that read mapped sequence-
reads from a binary sequence alignment/map file (with .bam extension) progressively and 
enumerate the reads mapping to the introns and exons: interest() capable of running in parallel on
several computing cores and interest.sequential() that runs only sequentially on a single core. In 
the latest release of IntEREst (v1.4.1) these two functions can be run in one or several modes to 
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count the intron mapping, exon-exon junction mapping and/or intron spanning reads. Several 
plotting tools are also supported by IntEREst. IntEREst requires a reference file that includes 
intron and exon coordinates. Either of Ensembl/RefSeq can be used to build the reference. Note 
that unless requested otherwise by the user (through the adjustable parameter settings) all 
overlapping exonic regions are collapsed to form large exonic regions in the reference and the 
remaining regions (with no overlapping exons) are considered as the intronic regions. 
Despite the relatively high performance of IntEREst (4.5 and 4.6), there are several general 
challenges that are shared with all RNAseq analyses. Poor RNAseq and mapping quality can 
affect the results and eventually lead to discovery of false significant IRs. Genomic DNA 
contamination in RNAseq libraries may also cause spurious increases in the levels of the 
detected intron-mapping reads. Techniques to control for this however exist. When visualizing 
the binary sequence alignment/map files (with .bam extension) using software such as IGV 
(Thorvaldsdóttir et al., 2013), if a high number of reads are mapped to the intergenic regions this 
indicates contamination of mRNAs with genomic DNA. A low percentage mapping of the reads 
to the genes is also another sign that the RNAseq libraries are contaminated with genomic DNA. 
Another source of noise in IR analysis is the presence of ribosomal RNAs (rRNAs) in the 
sample. Due to the high expression of rRNAs (i.e. up to 90% of the total RNA), they may bias 
the statistical differential IR analysis in IntEREst (especially if exon mapping reads are being 
analyzed). Therefor limiting the expression of rRNA using kits such as RiboMinus, filtering 
rRNA reads using SortMeRNA (Kopylova et al., 2012), and excluding the ribosomal RNA genes
from the reference can prevent biases that may be caused by these highly expressed RNAs. 
Filtering genes with low levels of intron mapping reads also improves the accuracy of detecting 
significant IRs (I, additional file 1). Read duplicates produced at the PCR duplication step of the 
sequencing may bias the results of the differential IR analysis; however, using a simple removal 
tool that filters all the duplicate reads (i.e. reads with exactly identical sequences that map to the 
same place in the genome) is not recommended since many of these reads may occur naturally; 
especially if they map to highly expressed genes (Bansal, 2017). Regions within the introns (or 
genes) that feature DNA repeats, or small RNAs (e.g. snoRNAs and miRNAs) can also affect the
read counts of the introns. If their coordinates are provided, IntEREst can excluded them from 
the IR analysis. However, if the coordinates of intron coded RNAs or regions with many aligned 
PCR duplicate reads are not known, read-peak finding tools such as macs (usually used for 
ChIP-seq analysis) can be used to discover these regions (Zhang et al., 2008). Recently, we 
received requests by several users to add two additional features to IntEREst (v1.4.1). One 
popular request was a downstream filtering function that removes the unreliably detected IRs, 
e.g. IRs that were detected based on low number of mapped reads. Additionally, implementation 
of an alternative IR normalization that is more suitable for cross-sample comparisons was 
requested. Although the FPKM normalization currently used  by IntEREst corrects the IR levels 
for length of the introns and the library size of the sequenced samples, they do not however sum 
to a constant value within a sample. In contrast, scaled IR levels that sum to a constant value 
within individual samples (e.g. Transcripts Per Million/TPM), facilitate a more accurate cross-
samples IR comparison. To address these issues, in future updates two functions will be added to 
IntEREst: An IR filtering function together with a function to scale the normalized levels such 
that the scaled IR levels in each sample would sum to a constant value (i.e. 1,000,000). 
The latest release of the packages can be accessed through https://bioconductor.org/packages/   
release/  bioc/html/IntEREst.html  , moreover the latest develop version is available in https://www  . 
bioconductor  .org  / packages/  devel/bioc/html/IntEREst.html  . 
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4.2. Global retention of U12-type introns
Earlier studies (Patel et al., 2002; Pessa et al., 2006) have provided experimental evidence that at
least some U12-type introns show elevated IR levels compared to the U2-type introns. To 
address if this is true for most or all of the U12-type introns we used genome-wide analysis to 
compare the IR of U12-type introns to that of U2-type in the same genes (I; II and III). In 
agreement with the earlier reports that focus on a few specific U12-type introns, in two of our 
studies (e.g. I and II) already the FPKM normalized read count values (I, formula 1) showed a 
global 2-fold higher retention of U12-type introns compared to the U2-type introns (I, figure 2a 
and b; II, figure 2C and S4).
In study II, a preliminary version of IntEREst together with MISO (Katz et al., 2010) was used 
to analyze SOLiD sequencing data derived from three individual Hep-2 cell pools (II). The Hep-
2 samples were part of an experiment to investigate the nuclear processing of the U12-type 
introns. Consequently, the Hep-2 cells were treated with siRNAs targeting RRP41 (i.e. a core 
component of the exosome), DIS3 (i.e. a catalytic subunit of the exosome) and GFP (green 
fluorescent protein used as a control) (II, figure S3).  Additionally, nuclei were separated from 
cytoplasm to increase the relative abundance of unspliced intron-containing pre-mRNAs 
compared to the spliced mRNAs. The nuclear fractions showed low levels of cytoplasmic 
contamination (<10%) and similarly, almost no nuclear contamination in cytoplasmic fractions 
were detected (II, figure 2B). Both nuclear and cytoplasmic samples were sequenced using 
SOLiD, followed by mapping with SoLiD Bioscope (II, table 1), after which the data was 
analyzed with IntEREst using a reference containing 544 annotated U12-type introns (that was 
built from RefSeq). A global 2-fold higher level of retained U12-type introns were observed 
compared to U2-type, either when analyzing reads that map to intron-exon junctions or when 
analyzing reads that fully map to the introns (II, figure 2C and S4). IR results based on intron-
exon junction mapping reads together with the validation of the most stabled introns (see below) 
ruled out the possibility that the observed increase in IR levels may had been influenced by the 
stabilization of excised intron lariats (II, figure S4). Similarly, a possibility that stable intron-
coded RNAs (miRNAs and snoRNAs) may influence the IR values was ruled out as no 
annotated intron-coded ncRNAs such as snoRNAs or miRNAs were detected within U12-type 
introns.
Subsequently, the evidence of increased IR of U12-type introns compared to U2-type has been 
seen in a great variety of samples, including bone marrow mononuclear cells (I), nuclear 
fractions from Hep-2 cells (II) and mononuclear blood cells (III). The effect was also observed in
6 studied maize control samples consisting of 3 roots and 3 shoots of maize (I, figure S7A and 
B), indicating that the higher retention of U12-type introns compared to U2-type is not limited to
mammals but extends to plants. Thus, while our results are in line with the earlier studies which 
claim that at least in a few individual genes U12-type introns are spliced less efficiently 
compared to the U2-type introns (Patel et al., 2002; Pessa et al., 2006), we can now generalize it 
to all U12-type introns in different organisms. 
Contrary to RNAs with retained U2-type introns (1.2.1), post-transcriptional splicing of the 
RNAs with retained U12-type introns has not been reported. Furthermore, the nuclear export of 
RNAs with retained U12-type introns has neither been seen in our studies (II, figure S2C and D),
nor been reported by others (Friend et al., 2008). However, there is accumulating evidence that 
the efficiency of splicing of U12-type introns may be regulated. One possible pathway for 
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regulation is a negative feedback loop that is described to regulate the levels of U11-48K and 
U11/U12-65K proteins in the complex that carries out the initial recognition of the U12-type 
intron (Verbeeren et al., 2010; Turunen, Verma, et al., 2013) and which has recently shown to be 
regulated during  neuronal differentiation (Verbeeren et al., 2017). The other possibility is the 
p38MAPK signaling pathway, which is known to regulate the stability of U6atac snRNA 
involved in the catalytic core of U12-dependent spliceosome. In this case, the stabilization of 
U6atac snRNA has been shown to correlate with an increase in mRNA levels of the genes 
containing U12-type introns (Younis et al., 2013).
4.3. Nuclear exosome degrades the transcripts containing 
U12-type introns
The overall retention of U12-type introns suggest that mRNA containing unspliced U12-type 
introns are retained in the nucleus and subsequently degraded. To identify the pathways 
involved, we hypothesized that the nuclear exosome (1.2.3) would be involved in the decay of 
the mRNAs containing unspliced U12-type introns. The hypothesis was based on a preliminary 
knock-down survey of various RNA degradation pathways on U12-type intron retention (II, 
figure 1). To test this possibility on a genome-wide scale we knocked down the key RRP41 and 
DIS3 subunits of the exosome and used RNAseq to investigate the possible stabilization of U12-
type intron signals. Consistently, with knock-down levels of 83% for DIS3 and 81% for RRP41 
(II, figure 2A), we observed 119 U12-type introns that were differentially retained (either higher 
or lower) in either of the exosome KD samples (DIS3/RRP41 KD) as compared to control (GFP 
KD) knock-down. The majority of the discovered U12 introns with high IR (i.e. 71 out of 119) 
were stabilized in the RRP41 KD samples rather than the DIS3 KD samples (II, figure 3A, B and
C). The stabilized introns (in RRP41 KD) not only featured higher retention levels than their 
flanking U2-type introns (II, figure 2C and 3D), but their retention levels were on average 2-fold 
higher than those in the control samples (II, figure 3C). The genes with stabilized introns 
included PSMC4, KIFAP and IFT80 (II, table S1) that were previously reported to feature U12-
type introns that splice less efficiently than their U2-type introns (Pessa et al., 2006; Singh and 
Padgett, 2009).  The number of significantly differentially retained U12-type introns in DIS3 KD
samples were less compared to RRP41 KD and they included more destabilized introns than 
stabilized. However, there were significant overlaps with the differentially retained U12 type 
introns extracted from the two exosome KD samples (p = 1.74E−10 for significantly higher 
retained U12 type introns and p = 0.0122 for significantly less retained, using hypergeometric 
test). When comparing the log fold-changes of the IR of U12-type introns (from control to the 
RRP41KD sample) to that of U2-type, it was also realized that their fold-change values were 
significantly higher than that of their immediate upstream/downstream U2-type introns or that of 
randomly sampled U2-type introns (p < 2.2E−16, using Jonckheere trend test; see II, figure 3F). 
The same significant increase was however not seen in the DIS3 KD (II, figure 3E). 
To validate the results, RT-qPCR was performed using two sets of primers: a pair to estimated 
the IR levels of U12-type introns and an additional pair to estimate the splicing levels of the U2-
type introns (II, figure 4A and B).  In detail, a reverse strand primer on the U12-type introns and 
a forward strand primer on the upstream exon flanking the U12-type introns were used for the 
former; and reverse and forward strand primers i.e. both located on the junction of the exons 
flanking the U2-type introns were used for the latter. These RT-qPCR results confirmed the 
exacerbation of IR upon RRP41 KD in 7 out of 8 genes that were detected using IntEREst. Note 
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that for the bioinformatics analysis in this study (II), the exact test function provided by IntEREst
(and adapted from edgeR) was used (considering a p < 0.05) and due to the short length of the 
read sequences used here (50+35 bps) the analysis were limited to only take into account reads 
that map to the introns (and did not incorporate any intron-spanning or exon-exon junction 
mapping reads). 
Previous reports have indicated that the exosome can regulate the processing and transcript 
termination of snRNAs e.g. U4 and U6 snRNAs (van Hoof et al., 2000; Schneider et al., 2012). 
To rule out the possibility that our exosome knockdowns could affect the IR by influencing the 
levels of spliceosomal snRNAs, we carried out Northern blot analysis of several U2/U12-
dependent snRNAs. We did not observe any changes in their expression levels upon exosome 
knockdown (II figure S2A and D). Hence (since no variation was observed), the changes in IR 
levels of the introns cannot be attributed to variations in the levels of snRNAs that are 
responsible for their splicing.  
In summary, the results indicate that the U12 type introns are preferentially stabilized upon the 
knock-down of exosome subunits. The stronger effect of RRP41 in comparison to DIS3 may be 
due to co-depletion of other exosome subunits such as RRP6 and other core subunits of exosome
in response to depletion of RRP41, i.e. a phenomenon that has also been seen in other studies 
(Kammler et al., 2008). Our results described here, together with the finding that conversion of 
U12-type introns to U2-type in U12-type intron containing genes has shown to upregulate the 
protein production  (Patel et al., 2002), support the hypothesis that U12-type introns are rate-
limiting factors that control the levels of the fully spliced mRNAs of the U12-type intron 
containing genes. Through this mechanism they may also limit the protein production of the 
U12-type intron containing genes.
The original hypothesis related to increased IR of U12-type introns postulated, based on in vitro 
splicing experiments, that splicing of U12-type introns is slower than U2-type introns (Patel et 
al., 2002). To test this possibility we compared the pre-mRNA decay kinetics of selected U12-
type introns to those of U2-type introns located in the same genes while the control and exosome
KD (Rrp41 KD and DIS3 KD) cells were treated with DRB (Singh and Padgett, 2009). This led 
to inhibition of CDK7 phosphorylation, which inhibits transcription initiation without 
influencing either the elongation of the transcripts or the processing of their pre-mRNAs. 
Our results (II, figure 4a-c) not only confirmed the higher IR of U12-type introns but also 
provided evidence that contradicted the original Patel et al. (2002) hypothesis. Specifically, the 
levels of U12-type introns leveled off but never reached zero; not even after 300 minutes (II, 
figure 4a-c). This was especially noticeable in the samples in which RRP41 was knocked down 
(II, figure 4a-c). Given that slow splicing entails that over time IR levels should reduce to zero, 
these results led us to hypothesize that the higher retention of U12-type introns to that of U2-type
may be the result of inefficient rather than slow splicing (Niemelä and Frilander, 2014). Slow 
splicing would also suggest that U12-type introns are spliced predominantly post-
transcriptionally, but the present evidence has reported only co-transcriptional splicing and it is 
not yet known whether these introns can undergo post-transcriptional splicing as well. Our 
observations suggest that a window of opportunity exists in which the U12-type introns can be 
spliced, but out of that window the introns will either be detained in the nucleus or degraded by 
the exosome. This limited window of opportunity may be caused by the exclusively co-
transcriptional splicing of the U12-type introns, or for other reasons that are currently unknown. 
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In the future, the inefficient vs slower splicing arguments may be settled by accurately estimating
the splicing rates of the U12-type introns (e.g. using in vivo single molecule microscopy) and 
comparing the measurements to those of the U2-type introns (Martin et al., 2013).
4.4. Consequences of minor spliceosome mutations 
In the study of a family with four daughters, three of which were affected by IGHD and pituitary 
hypoplasia (caused by defective U11/U12-65K protein), in addition to elevated levels of 
retention of U12-type introns (mentioned in subsection 4.2), several novel cryptic alternative 
splicing events were detected (III, figure 3G and S1-10). To name a few, expression of defective 
SPCS2/SPCS3 (i.e. associated with peptide hormone metabolism and gene expression) and 
ARPC5L (i.e. associated with actin binding GO category) were detected in the patient cells. 
Actually these mutations are the possible cause of the observed somatotroph-restricted 
dysfunction. These abnormal alternative splicing events were themselves the consequences of 
loss of function of U11/U12 di-snRNP due to its destabilization in the patient cells (caused by 
defective 65K). The loss of the integrity of the U11/U12 di-snRNP in the patient cells was 
validated by native gel analysis of nuclear extracts derived from IGHD patient cells and controls 
(III, figure 3A, lanes 3 and 4), in pull-down experiments using whole cell extracts (III, figure 3B 
and C) and glycerol gradient analyses (III, figure S11b) of the whole cell extracts. Furthermore, 
U12 snRNP with reduced mobility was detected in native gel analysis (III, figure 3B and C). 
Western blot results also showed significant decrease of 65K protein levels in the IGHD patient 
cells (III, figure 3D) which is consistent with a subsequent work (Norppa et al., 2018) showing 
that one of the IGHD alleles leads to formation of a premature STOP codon and allele-specific 
degradation by NMD pathway. Similarly, the other mutation leads to reduced binding to U12 
snRNA and likely degradation of the U11/U12-65K protein not bound to U12 snRNA (Norppa et
al., 2018).  Interestingly, we also observed an upregulation of U4atac snRNA in the patient cells. 
Similar upregulation can also be observed in the MDS patient dataset (unpublished) suggesting  
that it may be a compensatory effect for the decreased levels of U11/U12 di-snRNP, but the 
mechanism of its upregulation is not known at the present time. 
In another study (I) we reanalyzed, using IntEREst, the RNAseq data from 12 myelodysplastic 
syndrome (MDS) patients and 4 healthy individuals (Madan et al., 2015). Of the MDS patients, 8
featured mutations in the gene ZRSR2 that codes for the ZRSR2/Urp protein responsible for 
recognition of 3′ ss of U12 type introns (see 1.1.3). The outcomes showed  both an elevation of 
unspliced U12-type intron signal in ZRSR2 mutated samples (hereafter called ZRSR2mut) in 
comparison to the U2-type introns and also activation of cryptic U2-type splice sites near the 
U12-type introns  (I, figure 1a). After introns with low read counts were filtered and the DESeq2 
(Love et al., 2014) -based function of IntEREst (hereafter called IntEREst-DESeq2) was applied,
using an adjusted p-value cutoff (padj < 0.01), 1521 introns were detected to be significantly 
retained in ZRSR2mut compared to the controls. These controls include the 4 MDS patients that 
lack the ZRSR2 mutation (hereafter called ZRSR2wt) and the 4 healthy individuals (hereafter 
called HEALTHY). The significantly more retained introns in ZRSR2mut included 269 U12-
type introns i.e. 52.7% of the studied U12-type introns. In contrast, 1252 U2-type introns 
accounting for only ~0.54% of the studied U2-type introns showed increased IR (I, figure 1a and 
b). Moreover, while no U12-type introns were significantly less retained in the ZRSR2mut, 89 
U2-type introns (~0.03%) showed a significant decrease (I, figure 1a and b). 
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Increased IR of U12-type introns compared to the U2-type was observed in all samples (I, figure 
2a and b) and is consistent with slower/less efficient splicing of the U12-type introns (see 1.2.1 
and section 4.4). However, with ZRSR2mut samples this effect was more prominent (I, figure 2a 
and b). The log2 fold-change of FPKM values were also higher for the U12-type introns (~1.5) 
than that of U2-type (~ 0.0). This is an indication of IR exacerbation of U12-type introns in 
ZRSR2mut samples (I, figure 2c and d). Jonckheere Trend test with 10000 permutations also 
confirmed that the log fold-changes of U12-type introns are significantly higher than that of U2-
type introns (p = 0.0001). In-line with these results, the deltaPSI (ΔΨ ) measurements were 
almost twice higher for the U12-type introns (ΔΨ = 1%) compared to the U2-type (ΔΨ = 0.6%). 
The ΔΨ/deltaPsi measurement represents the changes in Ψ/PSI (Percentage Spliced In) when 
comparing two conditions.
A similar effect was observed in a maize data set investigating the effect of mutations in RGH3 
gene (i.e. an ortholog of human ZRSR2). This dataset consisted of 12 samples and showed both a 
≥2-fold higher retention of U12-type introns compared to U2-type and the exacerbation of IR of 
U12-type introns as a consequence of RGH3 mutations similarly as seen with human ZRSR2 
mutations (I, figure S7 A-D). The retention levels of ~46% of the studied U12-type introns were 
significantly increased in RGH3mut samples (comparing to RGH3wt). In contrast, only ~0.46% 
of the U2-type introns showed increase in their IR (I, figure S7 A-D).
In addition to increased IR levels of U12-type introns, additional splicing defects featuring the 
U2-type introns located next to the U12-type introns have been observed in several studies. In 
our study (III) RNAseq analyses and subsequent RT-PCR validations (III, figure 3G and S1-10) 
indicated exon skipping and activation of cryptic alternative U2-type introns in U12-type intron 
containing genes. Similar effects have also been reported with MDS dataset (Madan et al., 2015),
and in a knockout study investigating the functions of ZRSR1 (a paralog of ZRSR2, see 1.1.3) in 
mouse (Horiuchi et al., 2018). In these cases, the possible mechanism affecting the splicing of 
U2-type introns is disruption of exon-definition interactions between the neighboring U12-
dependent and U2-dependent spliceosome. The subsequent outcome of such events is either 
detention of the incorrectly processed mRNAs in the nucleus followed by their degradation, or in
case of cryptic splice site activation or exon skipping events formation of altered proteins or 
mRNA decay via the NMD pathway (Verma et al., 2018). 
One of the unexplained observations is the diverse phenotypic consequences seen with the 
hereditary disease-causing mutations in the human U12-dependent spliceosome component. 
They range from very severe i.e. significant developmental defects in multiple organs leading to 
early death as seen with MOPD1/TALS, to relatively benign diseases i.e. pituitary hypoplasia 
and associated dwarfism seen with IGHD that can be successfully treated with growth hormone 
injections (Martos-Moreno et al., 2018). Surprisingly, RNAseq data analysis of IGHD patients 
show several splicing defects including activation of cryptic alternative U2-type introns in U12-
type intron containing genes and nuclear detention of transcripts with retained U12-type introns. 
One possible explanation for the observed mild effects in IGHD in comparison to those observed
in MOPD1/TALS is that the cryptic splicing events in IGHD and other diseases may be 
eliminated by the NMD pathway. However, in contrast, accumulation of the unspliced U12-type 
introns that are observed in MOPD1/TALS patient cells may disrupt the actual functioning of the
U12-dependent spliceosome or other nuclear functions in the cell (Niemelä and Frilander, 2014; 
Verma et al., 2018).
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4.5. Comparison of the various  analysis modules supported 
by IntEREst
Detecting the genes/isoforms that are differentially expressed across various samples have been 
the main focus of many studies. To carry out these analysis a number of computational methods 
have been developed (1.3.3), namely the two widely popular R packages edgeR and DESeq 
(Robinson et al., 2010; Anders and Huber, 2010).  At the same time, due to the various 
limitations imposed by characteristics shared by many introns e.g. their large length and presence
of repetitive DNA sequences (see 1.3.4), accurate detection and differential analysis of isoforms 
containing retained introns have been challenging. In this respect, IntEREst attempts to carry out 
intron retention (IR) detection and cross-sample differential test by carrying out all its analysis at
the intron/exon level. Due to the success and the relatively high performance of edgeR and 
DESeq (1.3.3), IntEREst adapts these methods (together with DEXSeq) to perform statistical 
differential analysis. However, since these methods adapt different normalization and differential
analysis algorithms, despite their relatively high performance in detecting the differentially 
expressed isoforms, they typically produce somewhat different results (1.3.3). This motivated us 
to allow incorporation of any of the three DESeq2 (Love et al., 2014), edgeR (Robinson et al., 
2010) and DEXSeq (Anders et al., 2012; Reyes et al., 2013) methods (referred to as IntEREst-
DESeq2, IntEREst-edgeR and IntEREst-DEXSeq) to run differential IR analysis. Here, we 
compare the results that were obtained by running IntEREst-DESeq2, IntEREst-edgeR and 
IntEREst-DEXSeq on the MDS data (Madan et al., 2015). The results are not restricted to U12-
type introns but takes into account all differentially retained introns (including U12- or U2-type).
Note that for IntEREst-edgeR, the GLM function of edgeR was used.
The results indicated that although there were a number of significantly higher/lower retained 
introns that were discovered by each differential intron retention analysis function specifically, 
the majority of the discovered significantly high and low retained introns (in ZRSR2mut 
compared to controls) were shared between IntEREst-DESeq2 and IntEREst-edgeR (I, figure 3a 
and b). However, IntEREst-edgeR returned more significantly less retained introns than the 
IntEREst-DESeq2, whereas the latter found more significantly higher retained introns (I, figure 
3a and b). Interestingly, the IRs discovered by IntEREst-DESeq2 and missed by IntEREst-edgeR
mainly displayed weaker foldchange values compared to those discovered by both (I, figure S3). 
Despite the high overlap (both significantly more and less retained introns) between the 
IntEREst-DESeq2 and IntEREst-DEXSeq results, the latter discovered many cases that were not 
detected by IntEREst-DESeq2. Many of the IRs specific to IntEREst-DEXSeq were, however, 
proved to be false positives upon manual inspection. The higher and lower retained introns 
discovered by the IntEREst-DEXSeq actually featured a more symmetric distribution compared 
to those discovered by IntEREst-DESeq2 (I, figure S4). They were also featured from the same 
genes twice more frequently than the higher and less retained introns discovered by IntEREst-
DESeq2. Overall, the fact that IntEREst supports various settings of read summarization and 
various significant differential test functions allows the users to choose and apply their preferred 
method based on their data and biological questions. 
4.6. Benchmarking IR analysis tools including IntEREst
As mentioned previously various published methods exist to perform intron retention analysis 
(see subsection 1.3.4). We evaluated several of the existing methods that can be used to extract 
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IR events, namely IRFinder (Middleton et al., 2017), MISO (Katz et al., 2010), rMATS (Shen et 
al., 2014) and SUPPA (Alamancos et al., 2015; Trincado et al., 2018) and we compared their 
features to that of IntEREst. Some of these methods analyze variations of all alternative splicing 
events across the samples (e.g. MISO, SUPPA and rMATS), whereas others analyze intron 
retention specifically (e.g. IRFinder and KMA). Methods also differ based on whether their 
analysis can run in parallel on multiple computing cores, their supported sample size 
comparison, their support of complicated experiment designs to run sample comparison 
accordingly, their support of Ψ or PSI (i.e. Percentage Spliced In) values, their provided 
statistical tests to extract significantly retained introns, their support of IR comparison of 
subgroups of introns, or whether they annotate novel IRs i.e. absent from the used transcripts 
reference (table 4). 
All methods but SUPPA and KMA can be run on multiple computing cores in parallel. Apart 
from MISO that supports only a one-to-one sample comparison, all other methods allow 
comparisons of multiple samples to multiple samples, however, rMATS and SUPPA do not allow
one-to-one sample comparison (i.e. running without biological replication). Since IntEREst 
provides various advanced functions that are based on commonly used R packages for 
differential gene expression analysis (e.g. DESeq2 and edgeR), unlike the other methods it 
provides the possibility to define complicated experiment designs to perform IR differential 
analysis. This allows the running differential intron retention analysis while taking into account 
sample information such as age, sex etc. All methods support Ψ values calculation. SUPPA 
(version 1) was the only method that lacked statistical tests to discover differential IRs, however 
in its newest update this functionality has been added (Trincado et al., 2018). IntEREst is the 
only method that provides tools to compare between retention levels of various subgroups of 
introns (e.g. U12-type introns vs U2-type, or other user-defined groups). Moreover, IntEREst and
rMATS are the two methods that can discover novel IR events not present in their used transcript
references. Other methods that lack this capability (e.g. IRFinder and MISO) are dependent on 
transcriptome assembly tools e.g. Cufflinks (Trapnell et al., 2012) to detect novel significantly 
differential IRs.
Figure 5. Venn diagrams comparing the significantly retained introns (ZRSR2mut vs controls) that 
were discovered by IntEREst to those discovered by (a) rMATS with ΔΨ > 0.01% (b)  rMATS with 
ΔΨ > 20% (c) SUPPA (unpublished figure).
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Table 4. Various tools applicable for discovering significantly retained introns and performing 
differential IR analysis and their main features (unpublished).
Running IRFinder, 250 significantly increased IRs in ZRSR2mut samples (compared to controls)
were discovered most of which (i.e. 235) were also discovered by IntEREst-DESeq2 (I, figure 
3e). IntEREst-DESeq2 was also more sensitive to lower retained introns compared to IRFinder, 
discovering more introns with significant increase/decrease of IR (when comparing ZRSR2mut 
to the controls) despite their low mapped read counts (I, figure S5). When compared to the 
significant IRs discovered by the original MDS study (Madan et al., 2015) except for a few (i.e. 
37), all of the significantly increased IRs were also discovered by IntEREst. Most of the IRs 
missed by IntEREst featured very low IR log fold-changes in our analysis (I, figure S6). Due to 
lack of the possibility to use biological replicates, MISO was not applicable for analyzing the 
MDS data. Running rMATS with default parameters (i.e. cstat or cutoff splicing difference of 
0.0001 or 0.01%)  resulted in differential IRs drastically different from those extracted by 
IntEREst (figure 5a and b). Upon manual inspection, we realized that most of these introns were 
retained at high levels in both ZRSR2mut and control samples and the increase in the IR levels 
were not clear when comparing their retention in the ZRSR2mut, to that in the controls. In line 
with these observations, the log fold-change measurements of retention levels of the introns 
discovered by rMATS were relatively low regardless of whether the splicing difference cutoff (or
ΔΨ) parameter was set to 0.01% (figure 6a) or if it was set as high as 20% (figure 6b). Increasing
the rMATS ΔΨ cutoff parameter to 20% yielded results that featured less log fold-change IRs 
compared to when it was set to 0.01% (figure 6a and b). Running rMATS with the default 
parameter settings returned only 4 significantly less retained introns, all of which were discarded 
when the ΔΨ cutoff parameter was raised to 20%. Running SUPPA together with the diffsplice 
tool (Alamancos et al., 2015; Trincado et al., 2018) yielded only 3 significantly increased IRs, 1 
of which was also discovered by IntEREst (figure 5c); the other 2 IRs were missed by IntEREst 
due to the introns/genes being absent from the reference used by IntEREst. We were not able to 
successfully install/run KMA on the MDs data to obtain significant IRs.
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Figure 6. Scatter plot showing the distribution of log2 fold-change relative to the ΔΨ  values (when 
comparing ZRSR2mut to controls). The significant IRs discovered by IntEREst-DESeq2, rMATS or 
both have been labeled with different colours as depicted in the legend. The results of rMATS for 
two parameter settings are shown: (a) rMATS run with the default parameter settings, i.e. ΔΨ > 
0.01% and (b)  rMATS run with ΔΨ >  20% (unpublished figure).
As mentioned above, methods such as SUPPA and rMATS detect significant IRs by measuring 
the ΔΨ levels. They also implement statistical methods to infer the probability of reaching the 
observed ΔΨ values by chance (i.e. the significance of the observed ΔΨ). In contrast, IntEREst is
mainly based on raw read-counts of the introns/exons. Furthermore, IntEREst analyzes the 
changes of the number of intron mapping reads relative to the changes of the number of intron 
spanning reads. Admittedly, solely focusing on the fold change of the read levels does not 
completely reflect the changes in the fraction of various expressed isoforms of a gene. However, 
we have noticed that a number of isoforms, especially those with retained U12-type introns may 
be low expressed and feature Ψ measurements as low as 10% or less (I, Additional file 2). 
Detecting the possible ~2 fold increase of these isoforms in the test samples compared to that in 
controls are interesting even though this yields to a ΔΨ increase of 10%; which is usually 
neglected in other studies. This is particularly relevant for spliceosomal disease cases, where the 
defects are almost always hypomorphic and can lead to mild effects with individual introns, but 
nevertheless cause diseases upon influencing a large number of splicing events. In other words, 
by analyzing the genome-wide fold change of the IRs we can detect radical changes of IR levels 
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despite their low expressions. As a consequence however, a number of significantly differential 
IRs may also be incorrectly detected based on their extremely low average and high variance of 
intron read counts across the studied samples. For this reason IntEREst also supports Ψ (and ΔΨ)
values measurement tool, the results of which can be combined with traditional fold change 
measurements. We have found out that sorting the significant IRs by their cross-sample average 
Ψ values and filtering those with very low mean Ψ values can be helpful to focus on the most 
reliable detected IRs.
4.7. The effect of expanding biological replicates and the 
depth of sequencing libraries
Rerunning the IR detection analysis multiple times, while each time allowing either various 
number of samples or force the overall read counts (i.e. library depths) to different limits i.e. 5-
50 million, confirmed that including more biological replicates and reads both yield more 
detected significant IRs (II, figure 4a, b and c). However with the library size increase, the rise in
the number of discovered significant IRs was not linear and the slope decreased after reaching 
~35 million mapped reads (II, figure 4c). This trend was not seen for increase of the number of 
biological replicates, indicating that there remains room for increasing the number of biological 
replicates (beyond 16) and thus detect more significant IR results (II, figure 4a and b). This is 
probably due to the fact that the number of biological replicates in our MDS study was limited 
(i.e. 8 test samples vs 8 controls). However, a study that carried out differential gene expression 
analysis on a data with full set of 42 biological replicates claimed that at least 6 biological 
replicates are needed to be able to detect DEGs reliably. Furthermore they recommend that the 
number of biological replicates should be expanded to 12 if the goal is to detect DEGs with low 
fold-changes as well as the most extreme cases (Schurch et al., 2016). Given that IntEREst uses 
the similar tools that were developed for differential gene expression analysis (e.g. DESeq2 and 





Analyzing the retention of introns reveals information regarding the efficiency of splicing in 
various conditions. However, detecting and analyzing these retained introns using conventional 
isoform analysis software can be difficult due to several characteristics that are shared by most 
spliceosomal introns, e.g. they are large in length and they carry repetitive DNA sequences. I 
present in I a software tool called intron-exon retention estimator (IntEREst) that can be used to 
accurately detect, quantify and perform differential analysis of the intron retention in several 
samples, using RNAseq data from these samples. IntEREst also supports comparison of retention
levels of various subclasses of introns (e.g. U12-type introns vs U2-type). To test IntEREst in I, I
also reanalyzed data constructed from patients with myelodysplastic syndrome (MDS) and 
healthy individuals, confirming that mutations in the ZRSR2 gene (responsible for detection of 
3′ss of the U12-type introns) exacerbate the nuclear detention of the U12-type intron containing 
RNAs. 
Normally U12-type introns are spliced less efficiently and retained ~2 fold higher than the U2-
type introns, and therefore they are thought to be rate-limiting to the expression of transcripts 
that contain these introns. This was not previously studied at a genome-wide scale to our 
knowledge. The fate of the mRNAs that contain unspliced U12-type introns was not defined 
earlier. Using IntEREst, in II we show that there is a genome-wide higher (~2-fold) retention of 
U12-type introns compared to U2-type introns. We also show that the RNAs that contain 
unspliced U12-type introns are detected and degraded by the nuclear exosome. Furthermore, our 
results provide evidence that instead of being spliced slowly, the splicing of U12-type introns is 
in fact less efficient than that of U2-type introns.
Using other isoform analysis tools (e.g. Cufflinks), in III additional splicing abnormalities 
including activation of cryptic U2-dependent splice-sites and elevated retention of U2-type 
introns were also seen in patients diagnosed with isolated growth hormone deficiency (IGHD) 
caused by mutations in RNPC3, i.e. the gene coding for U11/U12-65K protein (III). Such defects
may have an impact on the severity of the diseases caused by minor spliceosome dysfunction.
Overall, this thesis demonstrates that applying isoform analysis software together with a 
dedicated intron retention analysis software tool such as IntEREst provides a comprehensive 
understanding of the biological pathways involved in diseases associated with defective 
spliceosome function. However, similarly as with any software, the development does not stop at
the first version. IntEREst currently (v1.4.1) lacks a comprehensive tool to filter the unreliable 
results (e.g. those based on low mapped-read counts). Moreover, the scaled (FPKM) IR levels do
not sum to constant values within the samples. In future updates, both of these shortcomings 
would be resolved by adding a downstream IR filtering function together with an additional 
function that scales the normalized values, thereby they will sum to a constant value (e.g. 1 
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